DSP (DSPG) 10-K16 Mar 152014 FY Annual reportFinancial data

Company Profile

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
Document And Entity Information (USD $)	Dec. 31, 2014	Mar. 06, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	DSP GROUP INC /DE/
Document Type	10-K
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		22,292,670
Entity Public Float			$110,662,000
Amendment Flag	FALSE
Entity Central Index Key	915778
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
CURRENT ASSETS:
Cash and cash equivalents	$20,544	$23,578
Restricted deposits	623	77
Marketable securities and short-term deposits (Note 3)	11,508	13,895
Trade receivables, net	20,298	21,195
Other accounts receivable and prepaid expenses (Note 4)	1,902	2,641
Inventories (Note 5)	15,635	12,334
Deferred income taxes (Note 15)	775	92
Total current assets	71,285	73,812
PROPERTY AND EQUIPMENT, NET (Note 6)	2,843	2,837
LONG-TERM ASSETS:
Long-term marketable securities (Note 3)	92,269	90,162
Long-term prepaid expenses and lease deposits	1,162	100
Deferred income taxes (Note 15)	149
Severance pay fund	10,860	11,168
Investment in other company (Note 9)	2,200	2,200
Intangible assets, net (Note 7)	5,135	6,710
Goodwill	5,276	5,276
	117,051	115,616
Total assets	191,179	192,265
CURRENT LIABILITIES:
Trade payables	15,282	14,149
Accrued compensation and benefits	9,408	9,845
Income tax accruals and payables	1,151	1,985
Accrued expenses and other accounts payable (Note 10)	5,852	5,532
Total current liabilities	31,693	31,511
LONG-TERM LIABILITIES:
Deferred income taxes (Note 15)	845	1,183
Accrued severance pay	10,929	11,179
Accrued pensions (Note 11)	1,089	981
Total long-term liabilities	12,863	13,343
COMMITMENTS AND CONTINGENCIES (Note 14)
STOCKHOLDERS' EQUITY (Note 13):
Common stock, $0.001 par value - Authorized: 50,000,000 shares at December 31, 2014 and 2013; Issued and outstanding: 21,843,950 and 22,349,780 shares at December 31, 2014 and 2013, respectively	22	22
Additional paid-in capital	355,906	350,494
Treasury stock at cost	-122,387	-118,749
Accumulated other comprehensive loss	-1,566	-821
Accumulated deficit	-85,352	-83,535
Total stockholders' equity	146,623	147,411
Total liabilities and stockholders' equity	$191,179	$192,265

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, authorized	50,000,000	50,000,000
Common stock, issued	21,843,950	22,349,780
Common stock, outstanding	21,843,950	22,349,780

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Revenues	$143,036		$151,063		$162,790
Costs of revenues (1)	85,992	[1]	91,237	[1]	101,660	[1]
Gross profit	57,044		59,826		61,130
Operating expenses:
Research and development, net (2)	33,468	[2]	35,000	[2]	42,539	[2]
Sales and marketing (3)	11,905	[3]	11,273	[3]	14,237	[3]
General and administrative (4)	10,541	[4]	11,812	[4]	10,638	[4]
Amortization of intangible assets	1,573		1,672		2,310
Restructuring expenses					2,008
Total operating expenses	57,487		59,757		71,732
Operating income (loss)	-443		69		-10,602
Financial income, net (Note 12)	1,204		2,457		2,388
Income (loss) before income tax benefit	761		2,526		-8,214
Income tax benefit	2,841		150		172
Net income (loss)	$3,602		$2,676		($8,042)
Net income (loss) per share:
Basic (in Dollars per share)	$0.16		$0.12		($0.37)
Diluted (in Dollars per share)	$0.16		$0.12		($0.37)
Weighted average number of shares used in per share computations of:
Basic net income (loss) per share (in Shares)	21,968		22,249		21,950
Diluted net income (loss) per share (in Shares)	22,954		22,906		21,950

[1]	Includes equity-based compensation expense in the amount of $300, $253 and $330 for the years ended December 31, 2014, 2013 and 2012, respectively.
[2]	Includes equity-based compensation expense in the amount of $2,381, $1,873 and $2,425 for the years ended December 31, 2014, 2013 and 2012, respectively.
[3]	Includes equity-based compensation expense in the amount of $621, $478 and $778 for the years ended December 31, 2014, 2013 and 2012, respectively.
[4]	Includes equity-based compensation expense in the amount of $2,057, $1,555 and $1,450 for the years ended December 31, 2014, 2013 and 2012, respectively.

Consolidated_Statements_of_Ope1

Consolidated Statements of Operations (Parentheticals) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Equity-based compensation expense included in cost of revenues	$300	$253	$330
Equity-based compensation expenses included in research and development, net	2,381	1,873	2,425
Equity-based compensation expense included in sales and marketing	621	478	778
Equity-based compensation expense included in general and administrative	$2,057	$1,555	$1,450

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Loss (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net income (loss):	$3,602	$2,676	($8,042)
Available-for-sale securities:
Changes in unrealized gains/losses	157	-304	2,621
Reclassification adjustments for gains included in net income (loss)	-61	-1,009	-670
Net change	96	-1,313	1,951
Cash flow hedges:
Changes in unrealized gains/losses	-1,180	372	635
Reclassification adjustments for (gains) losses included in net income (loss)	562	-856	325
Net change	-618	-484	960
Change in unrealized components of defined benefit plans:
Losses arising during the period	-209	-11	-161
Amortization of actuarial loss and prior service benefit	11	11	2
Net change	-198		-159
Foreign currency translation adjustments, net	-25	-12	-8
Other comprehensive income (loss)	-745	-1,809	2,744
Comprehensive income (loss)	$2,857	$867	($5,298)

Statements_of_Changes_In_State

Statements of Changes In Statements of Stockholders' Equity (USD $)	Common Stock [Member]		Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Total
In Thousands, except Share data	Common Stock [Member]		Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2011	$23		$341,352	($122,236)	($1,756)	($68,759)	$148,624
Balance (in Shares) at Dec. 31, 2011	22,502,000
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan		[1]		4,485		-2,507	1,978
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan (in Shares)	446,000
Issuance of treasury		[1]		86		-86
Issuance of treasury (in Shares)	9,000
Purchase of treasury stock	-1			-8,059			-8,060
Purchase of treasury stock (in Shares)	-1,283,000						1,283,000
Equity-based compensation expenses			4,983				4,983
Net income (loss)						-8,042	-8,042
Change in Accumulated other comprehensive income					2,744		2,744
Balance at Dec. 31, 2012	22		346,335	-125,724	988	-79,394	142,227
Balance (in Shares) at Dec. 31, 2012	21,674,000
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan		[1]		3,668		-2,004	1,664
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan (in Shares)	374,000
Issuance of treasury	1			6,796		-4,813	1,984
Issuance of treasury (in Shares)	692,000
Purchase of treasury stock	-1			-3,489			-3,490
Purchase of treasury stock (in Shares)	-390,000						390,000
Equity-based compensation expenses			4,159				4,159
Net income (loss)						2,676	2,676
Change in Accumulated other comprehensive income					-1,809		-1,809
Balance at Dec. 31, 2013	22		350,494	-118,749	-821	-83,535	147,411
Balance (in Shares) at Dec. 31, 2013	22,350,000
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan		[1]		3,031		-1,309	1,722
Issuance of treasury stock upon purchase of common stock under employee stock purchase plan (in Shares)	310,000
Issuance of treasury	1		53	5,814		-4,110	1,758
Issuance of treasury (in Shares)	598,000
Purchase of treasury stock	-1			-12,483			-12,484
Purchase of treasury stock (in Shares)	-1,414,000						1,414,000
Equity-based compensation expenses			5,359				5,359
Net income (loss)						3,602	3,602
Change in Accumulated other comprehensive income					-745		-745
Balance at Dec. 31, 2014	$22		$355,906	($122,387)	($1,566)	($85,352)	$146,623
Balance (in Shares) at Dec. 31, 2014	21,844,000

[1]	Represents an amount lower than $1.

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Net income (loss)	$3,602	$2,676	($8,042)
Adjustments required to reconcile net income (loss) to net cash provided by operating activities:
Depreciation	1,290	1,994	3,168
Equity-based compensation expenses related to employees' stock options, SARs and RSUs	5,359	4,159	4,983
Capital gain from sale and disposal of property and equipment			-57
Realized gain from sale of marketable securities	-61	-1,009	-670
Amortization of intangible assets	1,573	1,672	2,310
Accrued interest and amortization of premium on marketable securities and short-term deposits	1,214	747	1,295
Change in operating assets and liabilities:
Deferred income tax assets and liabilities, net	-1,170	-377	-12
Trade receivables, net	704	-767	5,281
Other accounts receivable and prepaid expenses	719	536	2,175
Inventories	-3,333	587	3,535
Long-term prepaid expenses and lease deposits	-1,052	153	264
Trade payables	1,142	121	-3,965
Accrued compensation and benefits	1,323	3,952	1,277
Income tax accruals and payables	-730	54	-705
Accrued expenses and other accounts payable	-289	-989	-567
Accrued severance pay, net	58	-228	-65
Accrued pensions	30	-31
Net cash provided by operating activities	10,379	13,250	10,205
Cash flows from investing activities:
Purchase of marketable securities	-70,517	-67,850	-75,483
Purchase of short-term deposits	-2,561	-2,849	-2,670
Proceeds from maturity of marketable securities	23,250	18,325	25,911
Proceeds from sales of marketable securities	46,491	42,949	39,063
Proceeds from redemption of short-term deposits	2,561	2,849	15,643
Proceeds from sales of property and equipment			81
Purchases of property and equipment	-1,315	-1,118	-1,094
Investment in other company		-2,200
Increase in restricted deposits	-556
Net cash provided by (used in) investing activities	-2,647	-9,894	1,451
Cash flows from financing activities:
Issuance of common stock and treasury stock upon exercise of stock options and SARs	1,758	1,984
Purchase of treasury stock	-12,484	-3,490	-8,060
Net cash used in financing activities	-10,726	-1,506	-8,060
Increase (decrease) in cash and cash equivalents	-2,994	1,850	3,596
Cash and cash equivalents at the beginning of the year	23,578	21,684	18,109
Cash (erosion) due to exchange rate differences	-40	44	-21
Cash and cash equivalents at the end of the year	20,544	23,578	21,684
Taxes on income	$131	$149	$149

Note_1_General

Note 1 - General	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	NOTE 1:-	GENERAL

	DSP Group, Inc., a Delaware corporation, and its subsidiaries (collectively, the "Company"), are a fabless semiconductor company offering advanced chipset solutions for a variety of applications. The Company is a worldwide leader in the short-range wireless communication market, enabling home networking convergence for voice, audio, video and data.

	The Company sells its products primarily through distributors and directly to OEMs and original design manufacturers (ODMs) who incorporate the Company's products into consumer and enterprise products. The Company's future performance will depend, in part, on the continued success of its distributors in marketing and selling its products. The loss of the Company's distributors and the Company's inability to obtain satisfactory replacements in a timely manner may harm the Company's sales and results of operations. In addition, the Company expects that a limited number of customers, varying in identity from period-to-period, will account for a substantial portion of its revenues in any period. The loss of, or reduced demand for products from, any of the Company's major customers could have a material adverse effect on the Company's business, financial condition and results of operations.

	Sales to Hong Kong-based VTech Holdings Ltd. ("VTech") represented 35%, 36% and 35% of the Company's total revenues for 2014, 2013 and 2012, respectively. Revenues derived from sales through one distributor, Tomen Electronics Corporation ("Tomen Electronics"), accounted for 20%, 19% and 21% of the Company's total revenues for 2014, 2013 and 2012, respectively. Tomen Electronics sells the Company's products to a limited number of customers. One customer, Panasonic Communications Co., Ltd. ("Panasonic"), has continually accounted for a majority of the sales of Tomen Electronics. Sales to Panasonic through Tomen Electronics generated approximately 15%, 14% and 15% of the Company's total revenues for 2014, 2013 and 2012, respectively. Additionally, sales to Uniden America Corporation ("Uniden") represented 2%, 4% and 11% of the Company's total revenues for 2014, 2013 and 2012, respectively. The Japanese and Hong Kong markets and the OEMs that operate in those markets are among the largest suppliers in the world with significant market share in the U.S. market for residential wireless products.

	The majority of the revenues derived from the above mentioned customers are included to the Home segment.

	All of the Company's integrated circuit products are manufactured and tested by independent foundries and test houses. While these foundries and test houses have been able to adequately meet the demands of the Company's business, the Company is and will continue to be dependent upon these foundries and test houses to achieve acceptable manufacturing yields, quality levels and costs, and to allocate to the Company a sufficient portion of foundry and test capacity to meet the Company's needs in a timely manner. Revenues could be materially and adversely affected should any of these foundries and test houses fail to meet the Company's request for product manufacturing due to a shortage of production capacity, process difficulties, low yield rates or financial instability. Additionally, certain of the raw materials, components, and subassemblies included in the products manufactured by the Company's original equipment manufacturer (OEM) customers, which incorporate the Company's products, are obtained from a limited group of suppliers. Disruptions, shortages, or termination of certain of these sources of supply could occur and could negatively affect the Company's financial condition and results of operations.

Note_2_Significant_Accounting_

Note 2 - Significant Accounting Policies

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

NOTE 2:-

SIGNIFICANT ACCOUNTING POLICIES

The consolidated financial statements are prepared according to United States generally accepted accounting principles (“U.S. GAAP”).

Use of estimates:

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Financial statements in U.S. dollars:

Most of the Company’s revenues are generated in U.S. dollars ("dollar"). In addition, a substantial portion of the Company’s costs are incurred in dollars. The Company's management believes that the dollar is the currency of the primary economic environment in which the Company operates. Thus, the functional and reporting currency of the Company is the dollar.

Monetary accounts maintained in currencies other than the dollar are remeasured into dollars in accordance with ASC No. 830-30, "Translation of Financial Statements." All transaction gains and losses resulting from the remeasurement of monetary balance sheet items are reflected in the consolidated statements of operations as financial income or expenses as appropriate.

The financial statements of the Company's subsidiary – DSP Group Technologies GmbH whose functional currency is not the dollar, has been translated into dollars. All amounts on the balance sheets have been translated into the dollar using the exchange rates in effect on the relevant balance sheet dates. All amounts in the consolidated statements of operations have been translated into the dollar using the average exchange rate for the relevant periods. The resulting translation adjustments are reported as a component of accumulated other comprehensive income (loss) in changes in stockholders' equity.

Accumulated other comprehensive loss related to foreign currency translation adjustments, net amounted to $218 and $193 as of December 31, 2014 and 2013, respectively.

Principles of consolidation:

The consolidated financial statements include the accounts of the Company. Intercompany transactions and balances have been eliminated in consolidation.

Cash and cash equivalents:

Cash equivalents are short-term highly liquid investments, which are readily convertible to cash with original maturity of three months or less from the date of acquisition.

Restricted deposits:

Restricted deposits include deposits which are used as security for derivative instruments and for one of the Company's lease agreements.

Short-term deposits:

Bank deposits with original maturities of more than three months and less than one year are presented at cost, including accrued interest.

Marketable securities:

The Company accounts for investments in debt securities in accordance with FASB ASC No. 320-10, "Investments in Debt and Equity Securities." Management determines the appropriate classification of the Company's investments in debt securities at the time of purchase and reevaluates such determinations at each balance sheet date.

The Company classified all of its investments in marketable securities as available for sale.

Available-for-sale securities are carried at fair value, with the unrealized gains and losses, reported in other comprehensive income (loss) using the specific identification method. Unrealized losses determined to be other-than-temporary are recorded as a financial expense. The amortized cost of marketable securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization is included in financial income, net. Interest and dividends on securities are included in financial income, net.

The marketable securities are periodically reviewed for impairment. If management concludes that any of these investments are impaired, management determines whether such impairment is other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value and the potential recovery period, and the Company's intent to sell, or whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. For debt securities, only the decline attributable to deteriorating credit of an-other-than-temporary impairment is recorded in the consolidated statement of operations, unless the Company intends, or more likely than not it will be forced, to sell the security. During the years ended December 31, 2014, 2013 and 2012, the Company did not record an-other-than-temporary impairment loss (see Note 3).

Fair value of financial instruments:

Cash and cash equivalents, restricted deposits, short-term deposits, trade receivables, trade payables and accrued liabilities approximate fair value due to short term maturities of these instruments. Marketable securities and derivative instruments are carried at fair value. See Note 3 for more information.

Fair value is an exit price, representing the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in valuation methodologies to measure fair value:

Level 1-

Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2-

Include other inputs that are directly or indirectly observable in the marketplace.

Level 3-

Unobservable inputs which are supported by little or no market activity.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

Inventories:

Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.

The Company and its subsidiaries periodically evaluate the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its market value.

Cost is determined as follows:

Work in progress and finished products- on the basis of raw materials and manufacturing costs on an average basis.

The Company regularly evaluates the ability to realize the value of inventory based on a combination of factors, including the following: historical usage rates and forecasted sales according to outstanding backlogs. Purchasing requirements and alternative usage are explored within these processes to mitigate inventory exposure. When recorded, the reserves are intended to reduce the carrying value of inventory to its net realizable value. Inventory of $15,635 and $12,334 as of December 31, 2014 and 2013, respectively, is stated net of inventory reserves of $505 and $591 in each year, respectively. If actual demand for the Company's products deteriorates, or market conditions are less favorable than those projected, additional inventory reserves may be required.

Property and equipment, net:

Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, at the following annual rates:

Computers and equipment

20 - 33

Office furniture and equipment

15-Jun

Leasehold improvements

The shorter of term of the lease or the useful life of the asset

Property and equipment of the Company are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The recoverability of assets to be held and used is measured by a comparison of the carrying amount of such assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.

During the years ended December 31, 2014, 2013 and 2012, no impairment losses were identified for property and equipment.

The Company accounts for costs of computer software developed or obtained for internal use in accordance with FASB ASC No. 350-40, "The Internal Use Software." FASB ASC 350-40 requires the capitalization of certain costs incurred in connection with developing or obtaining internal use software. During 2014, 2013 and 2012, the Company capitalized $128, $34 and $22, respectively, of internal use software cost. Such costs are amortized using the straight-line method over their estimated useful life of three years.

Goodwill and other intangible assets:

The goodwill and certain other purchased intangible assets have been recorded as a result of the BoneTone Acquisition and the CIPT Acquisition. Goodwill represents the excess of the purchase price in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill is not amortized, but rather is subject to an annual impairment test.

ASC 350 prescribes a two-phase process for impairment testing of goodwill. The first phase screens for impairment, while the second phase (if necessary) measures impairment. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value. In such a case, the second phase is then performed, and the Company measures impairment by comparing the carrying amount of the reporting unit’s goodwill to the implied fair value of that goodwill. An impairment loss is recognized in an amount equal to the excess. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. An entity is not required to calculate the fair value of a reporting unit unless the entity determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount.

Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test.

The Company performs an annual impairment test on December 31 of each fiscal year, or more frequently if impairment indicators are present.

The Company's reporting units are consistent with the reportable segments identified in Note 18.

Fair value is determined using discounted cash flows, market multiples and market capitalization. Significant estimates used in the methodologies include estimates of future cash-flows, future short-term and long-term growth rates, weighted average cost of capital and market multiples for the reporting unit.

For the fiscal year ended December 31, 2014, 2013 and 2012, the Company performed a quantitative assessment on its goodwill and no impairment losses were identified.

Intangible assets that are not considered to have an indefinite useful life are amortized using the straight-line basis over their estimated useful lives, which range from 3 to 7.3 years. The carrying amount of these assets is reviewed whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Recoverability of these assets is measured by comparison of the carrying amount of the asset to the future undiscounted cash flows the asset is expected to generate.

If such asset is considered to be impaired, the impairment to be recognized is measured as the difference between the carrying amount of the assets and the fair value of the impaired asset.

During 2014, 2013 and 2012, no impairment losses were identified.

Severance pay:

DSP Group Ltd., the Company's Israeli subsidiary ("DSP Israel"), has a liability for severance pay pursuant to Israeli law, based on the most recent monthly salary of its employees multiplied by the number of years of employment as of the balance sheet date for such employees. DSP Israel's liability is fully provided for by monthly accrual and deposits with severance pay funds and insurance policies.

The deposited funds include profits accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israel's Severance Pay Law or labor agreements.

Severance expenses for the years ended December 31, 2014, 2013 and 2012, were $1,568, $1,494 and $1,660, respectively.

Revenue recognition:

The Company generates its revenues from sales of products. The Company sells its products through a direct sales force and through a network of distributors.

Product sales are recognized when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable, collectability is reasonably assured, and no significant obligations remain.

Persuasive evidence of an arrangement exists - The Company's sales arrangements with customers are pursuant to written documentation, either a written contract or purchase order. The actual documentation used is dependent on the business practice with each customer. Therefore, the Company determines that persuasive evidence of an arrangement exists with respect to a customer when it has a written contract, or a written purchase order from the customer.

Delivery has occurred - Each written documentation relating to a sale arrangement that is agreed upon with the customer specifically sets forth when risk and title are being transferred (based on the agreed International Commercial terms, or "INCOTERMS"). Therefore, the Company determines that risk and title are transferred to the customer when the terms of the written documentation based on the applicable INCOTERMS are satisfied and thus delivery of its products has occurred.

Separately, the Company has consignment inventory which is held for specific customers at the customers' premises. It recognizes revenue on the consigned inventory when the customer consumes the products from the warehouse, as that is when per the consignment inventory agreements, risk and title passes to the customer and the products are deemed delivered to the customer.

The fee is fixed or determinable - Pursuant to the customer agreements, the Company does not provide any price protection, stock rotation, right of return and/or other discount programs and thus the fee is considered fixed and determinable upon execution of the written documentation with the customers. Additionally, payments that are due within the normal course of the Company's credit terms, which are currently no more than four months from the contract date, are deemed to be fixed and determinable based on the Company's successful collection history for such arrangements.

Collectability is reasonably assured - The Company determines whether collectability is reasonably assured on a customer-by-customer basis pursuant to its credit review policy. The Company typically sells to customers with whom it has a long-term business relationship and a history of successful collection. A significant number of the Company's customers are also large original equipment manufacturers with substantial financial resources. For a new customer, or when an existing customer substantially expands its commitments, the Company evaluates the customer's financial position, the number of years the customer has been in business, the history of collection with the customer and the customer's ability to pay and typically assigns a credit limit based on that review. The Company increases the credit limit only after it has established a successful collection history with the customer. If the Company determines at any time that collectability is not reasonably assured under a particular arrangement based upon its credit review process, the customer's payment history or information that comes to light about a customer's financial position, it recognizes revenue under that arrangement as customer payments are actually received.

With respect to product sales through the Company's distributors, such product revenues are deferred until the distributors resell the Company's products to the end-customers ("sell through") and recognized based upon receipt of reports from the distributors, provided all other revenue recognition criteria as discussed above are met.

The Company views its distributor arrangements as that of consignment because, although the actual sales are conducted through the distributors and legally title for the products passes to the distributors upon delivery to the distributors, in substance inventory is simply being transferred to another location for sale to the end-user customers as the Company's primary business relationships and responsibilities are directly with the end-user customers. Because the Company views its arrangements with its distributors as that of consignment relationships, delivery of goods is not deemed to have occurred solely upon delivery to the distributors. Therefore, the Company recognizes revenues from distributors under the "sell-through" method. As a result, revenue is deferred at the time of shipment to the distributors and is recognized only when the distributors sell the products to the end-user customers.

Warranty:

The Company warrants its products against errors, defects and bugs for generally one year. The Company estimates the costs that may be incurred under its warranty and records a liability in the amount of such costs. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Warranty costs and liability were immaterial for the years ended December 31, 2014, 2013 and 2012.

Research and development costs, net:

Research and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.

Government grants:

Government grants received by the Company’s Israeli subsidiary relating to categories of operating expenditures are credited to the consolidated statements of income during the period in which the expenditure to which they relate is charged. Royalty and non-royalty-bearing grants from the Israeli Office of the Chief Scientist ("OCS") for funding certain approved research and development projects are recognized at the time when the Company’s Israeli subsidiary is entitled to such grants, on the basis of the related costs incurred, and are included as a deduction from research and development expenses, net.

The Company recorded royalty bearing grants in the amount of $3,002 and $2,116 for the year ended December 31, 2014 and 2013, respectively. In 2012, the Company recorded non-royalty-bearing grants from the OCS in the amount of $386.

The Company’s Israeli subsidiary is obligated to pay royalties amounting to 5% of the sales of certain products the development of which received grants from the OCS in previous years. The obligation to pay these royalties is contingent on actual sales of such products. Grants received from the OCS may become repayable if certain criteria under the grants are not met. The Israeli Research and Development Law provides that know-how developed under an approved research and development program may not be transferred to third parties without the approval of the OCS. Such approval is not required for the sale or export of any products resulting from such research or development. The OCS, under special circumstances, may approve the transfer of OCS-funded know-how outside Israel, in the following cases: (a) the grant recipient pays to the OCS a portion of the sale price paid in consideration for such OCS-funded know-how or in consideration for the sale of the grant recipient itself, as the case may be, which portion will not exceed six times the amount of the grants received plus interest (or three times the amount of the grant received plus interest, in the event that the recipient of the know-how has committed to retain the R&D activities of the grant recipient in Israel after the transfer); (b) the grant recipient receives know-how from a third party in exchange for its OCS-funded know-how; (c) such transfer of OCS-funded know-how arises in connection with certain types of cooperation in research and development activities; or (d) if such transfer of know-how arises in connection with a liquidation by reason of insolvency or receivership of the grant recipient.

Equity-based compensation:

At December 31, 2014, the Company had two equity incentive plans from which the Company may grant future equity awards and three expired equity incentive plans from which no future equity awards may be granted but had outstanding equity awards granted prior to expiration. The Company also had one employee stock purchase plan. See full description in Note 13.

The Company accounts for equity-based compensation in accordance with FASB ASC No. 718, "Stock Compensation" ("FASB ASC No. 718"). FASB ASC No. 718 requires companies to estimate the fair value of equity-based awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statements of operations.

The Company recognizes compensation expenses for the value of its awards granted based on the accelerated attribution method, rather than a straight-line method over the requisite service period of each of the awards, net of estimated forfeitures. FASB ASC No. 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Estimated forfeitures are based on actual historical pre-vesting forfeitures.

FASB ASC No. 718 requires cash flows resulting from tax deductions in excess of the compensation costs recognized for those equity-based awards to be classified as financing cash flows.

The Company selected the lattice option pricing model as the most appropriate fair value method for its equity-based awards and values options and stock appreciation rights (SARs) based on the market value of the underlying shares on the date of grant. The option-pricing model requires a number of assumptions, of which the most significant are the expected stock price volatility and the expected term of the equity-based award. Expected volatility is calculated based upon actual historical stock price movements. The expected term of the equity-based award granted is based upon historical experience and represents the period of time that the award granted is expected to be outstanding. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has historically not paid dividends and has no foreseeable plans to pay dividends.

Basic and diluted income (loss) per share:

Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding during the year. Diluted net income (loss) per share further include the dilutive effect of stock options, stock appreciation rights (SARs) and restricted stock units (“RSUs”) outstanding during the year, all in accordance with FASB ASC No. 260, "Earnings Per Share."

The total weighted average number of shares related to the outstanding stock options, SARs and RSUs excluded from the calculation of diluted net income (loss) per share due to their anti-dilutive effect was 1,811,687, 2,730,867 and 7,584,336 for the years ended December 31, 2014, 2013 and 2012, respectively.

Income taxes:

The Company accounts for income taxes in accordance with FASB ASC No. 740, "Income Taxes." This topic prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

Deferred tax liabilities and assets are classified as current or non-current based on the classification of the related asset or liability for financial reporting, or according to the expected reversal dates of the specific temporary differences if not related to an asset or liability for financial reporting.

The Company accounts for uncertain tax positions in accordance with ASC 740, which contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining whether the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company reevaluates its income tax positions periodically to consider factors such as changes in facts or circumstances, changes in or interpretations of tax law, effectively settled issues under audit, and new audit activity. Such a change in recognition or measurement would result in recognition of a tax benefit or an additional charge to the tax provision.

The Company includes interest related to tax issues as part of income tax expense in its consolidated financial statements. The Company records any applicable penalties related to tax issues within the income tax provision.

Concentrations of credit risk:

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted deposits, short-term deposits, trade receivables and marketable securities.

The majority of cash and cash equivalents and short-term deposits of the Company are invested in dollar deposits with major U.S., European and Israeli banks. Deposits in U.S. banks may be in excess of insured limits and are not insured in other jurisdictions. Generally, cash and cash equivalents and these deposits may be withdrawn upon demand and therefore bear low risk.

The Company's marketable securities consist of investment-grade corporate bonds and U.S. government-sponsored enterprise ("GSE") securities. As of December 31, 2014, the amortized cost of the Company's marketable securities was $101,474, and their stated market value was $101,178, representing an unrealized loss of $296.

A significant portion of the products of the Company is sold to original equipment manufacturers of consumer electronics products. The customers of the Company are located primarily in Japan, Hong Kong, Taiwan, China, Korea, Europe and the United States. The Company performs ongoing credit evaluations of their customers. A specific allowance for doubtful accounts is determined, based on management's estimates and historical experience. Under certain circumstances, the Company may require a letter of credit. The Company covers most of its trade receivables through credit insurance. As of December 31, 2014 and 2013, no allowance for doubtful accounts was provided.

The Company has no off-balance-sheet concentration of credit risk, except for certain derivative instruments as mentioned below.

Derivative instruments:

The Company accounts for derivatives and hedging based on FASB ASC No. 815,"Derivatives and Hedging". ASC No. 815 requires companies to recognize all of their derivative instruments as either assets or liabilities on the balance sheet at fair value.

For derivative instruments that are designated and qualify as a cash flows hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the effective portion of the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Any gain or loss on a derivative instrument in excess of the cumulative change in the present value of future cash flows of the hedged item is recognized in current earnings during the period of change.

To protect against the increase in value of forecasted foreign currency cash flows resulting from salary and rent payments in New Israeli Shekel ("NIS") during the year, the Company instituted a foreign currency cash flow hedging program. The Company hedges portions of the anticipated payroll and rent of its Israeli facilities denominated in NIS for a period of one to 12 months with put and call options and forward contracts. These forward contracts and put and call options are designated as cash flow hedges and are all effective as hedges of these expenses.

The fair value of the outstanding derivative instruments at December 31, 2014 and 2013 is summarized below:

Fair value of

derivative instruments

Derivative assets

As of December 31,

(liabilities)

Balance sheet location

2014

2013

Foreign exchange forward contracts and put and call options

Accrued expenses and other accounts payable

(618

)

Total

(618

)

The effect of derivative instruments in cash flow hedging transactions on income and other comprehensive income ("OCI") for the years ended December 31, 2014, 2013 and 2012 is summarized below:

Gains (losses) on derivatives

recognized in OCI

Year ended December 31,

2014

2013

2012

Foreign exchange forward contracts and put and call options

(1,180

)

372

635

Gains (losses) on derivatives reclassified

from OCI to income

Year ended December 31,

Location

2014

2013

2012

Foreign exchange forward contracts and put and call options

Operating expenses

(562

)

856

(325

)

As of December 31, 2014 and 2013, the Company had outstanding option contracts in the amount of $16,575 and $0, respectively.

Comprehensive income:

The Company accounts for comprehensive income in accordance with FASB ASC No. 220, "Comprehensive Income.". Comprehensive income generally represents all changes in stockholders' equity during the period except those resulting from investments by, or distributions to, stockholders. The Company determined that its items of other comprehensive income relate to gains and losses on hedging derivative instruments, unrealized gains and losses on available-for-sale securities, unrealized gains and losses from pension and unrealized gain and losses from foreign currency translation adjustments.

The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for 2014:

Unrealized gains (losses) on available-for-sale marketable securities

Unrealized gains (losses) on Cash Flow Hedges

Unrealized gains (losses) on components of defined benefit plans

Unrealized gains (losses) on foreign currency translation

Total

Beginning balance

(391

)

(237

)

(193

)

(821

)

Other comprehensive income (loss) before reclassifications

157

(1,180

)

(209

)

(25

)

(1,257

)

Amounts reclassified from accumulated other comprehensive income (loss)

(61

)

562

512

Net current period other comprehensive income (loss)

(618

)

(198

)

(25

)

(745

)

Ending balance

(295

)

(618

)

(435

)

(218

)

(1,566

)

The following table provides details about reclassifications out of accumulated other comprehensive income (loss) for 2014:

Details about Accumulated

Amount

Affected Line Item in the

Other Comprehensive Income

Reclassified from

Statement of Income (Loss)

(Loss) Components

Accumulated Other

Comprehensive

Income (Loss)

(In millions)

Gains on available-for-sale marketable securities

(61

)

Financial income, net

Provision for income taxes

(61

)

Total, net of income taxes

Gains on cash flow hedges

441

Research and development

Sales and marketing

General and administrative

562

Total, before income taxes

Provision for income taxes

562

Total, net of income taxes

Income on components of defined benefit plans

Research and development

Sales and marketing

Total, before income taxes

Provision for income taxes

Total, net of income taxes

Total reclassifications for the period

512

Total, net of income taxes

Treasury stock at cost

The Company repurchases its common stock from time to time on the open market or in other transactions and holds such shares as treasury stock. The Company presents the cost to repurchase treasury stock as a reduction of stockholders' equity.

From time to time, the Company reissues treasury stock under its employee stock purchase plan and equity incentive plans, upon purchases or exercises of equity awards under the plans. When treasury stock is reissued, the Company accounts for the re-issuance in accordance with ASC No. 505-30, "Treasury Stock" and charges the excess of the purchase cost over the re-issuance price (loss) to retained earnings. The purchase cost is calculated based on the specific identification method. In case the purchase cost is lower than the re-issuance price, the Company credits the difference to additional paid-in capital.

Investment in other company:

Investment in other company is stated at cost. The Company followed ASC 323, "Investments - Equity and Joint Ventures", to determine whether it should apply the equity method of accounting to investment in other than common stock with regard to a certain investment in preferred shares, and determined that the preferred shares are not in substance common stock.

The Company's investment in other company is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an investment may not be recoverable, in accordance with ASC 325-20. As of December 31, 2014, no impairment loss was indicated (see also Note 9).

The impact of recently issued accounting standards (not effective for the Company as of December 31, 2014) is as follows:

In May 2014, the FASB issued an accounting standard update on revenue from contracts with customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The new guidance will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. The new standard will be effective for the Company on July 1, 2017. Early application is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company is currently evaluating the effect that the new guidance will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.

Note_3_Marketable_Securities_a

Note 3 - Marketable Securities and Time Deposits	12 Months Ended
Note 3 - Marketable Securities and Time Deposits	Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	NOTE 3:	MARKETABLE SECURITIES AND TIME DEPOSITS

	The following is a summary of marketable securities and time deposits at December 31, 2014 and 2013 (see also Note 8):

			Amortized cost				Unrealized gains (losses), net						Fair value
			2014		2013		2014			2013			2014		2013

	Short term deposit		$	2,599	$	2,911	$	-		$	-		$	2,599	$	2,911
	U.S. GSE securities			21,085		3,093		(34	)		(11	)		21,051		3,082
	Corporate obligations			80,389		98,444		(262	)		(380	)		80,127		98,064

			$	104,072	$	104,448	$	(296	)	$	(391	)	$	103,777	$	104,057

	The amortized cost of marketable debt securities at December 31, 2014, by contractual maturities or anticipated dates of sale, are shown below:

			Amortized		Unrealized gains (losses)					Fair
			cost		Gains		Losses			value

	Due in one year or less		$	8,910	$	4	$	(5	)	$	8,909
	Due after one year to five years			92,564		110		(405	)		92,269

			$	101,474	$	114	$	(410	)	$	101,178

	The amortized cost of marketable debt securities at December 31, 2013, by contractual maturities or anticipated dates of sale, are shown below:

			Amortized		Unrealized gains (losses)					Fair
			cost		Gains		Losses			value

	Due in one year or less		$	10,961	$	23	$	-		$	10,984
	Due after one year to six years			90,576		162		(576	)		90,162

			$	101,537	$	185	$	(576	)	$	101,146

	The actual maturity dates may differ from the contractual maturities because debtors may have the right to call or prepay obligations without penalties.

	The total fair value of marketable securities with outstanding unrealized losses as of December 31, 2014 amounted to $68,945, while the unrealized losses for these marketable securities amounted to $410. Of the $410 unrealized losses outstanding as of December 31, 2014, a portion of which in the amount of $113 was related to marketable securities that were in a loss position for more than 12 months and the remaining portion of $297 was related to marketable securities that were in a loss position for less than 12 months.

	The total fair value of marketable securities with outstanding unrealized losses as of December 31, 2013 amounted to $46,943, while the unrealized losses for these marketable securities amounted to $576. Of the $576 unrealized losses outstanding as of December 31, 2013, a portion of which in the amount of $145 was related to marketable securities that were in a loss position for more than 12 months and the remaining portion of $431 was related to marketable securities that were in a loss position for less than 12 months.

	Management believes that as of December 31, 2014, the unrealized losses in the Company's investments in all types of marketable securities were temporary and no impairment loss was realized in the Company's consolidated statements of operations.

	The unrealized losses related to the Company’s marketable securities were primarily due to changes in interest rates. Because the Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be maturity, the Company does not consider those investments to be other-than-temporarily impaired at December 31, 2014.

	Proceeds from maturity of available-for-sale marketable securities during 2014, 2013 and 2012 were $23,250, $18,325 and $25,911, respectively. Proceeds from sales of available-for-sale marketable securities during 2014, 2013 and 2012 were $46,491, $42,949 and $39,063, respectively. Realized gains from the sale of available-for sale marketable securities for 2014, 2013 and 2012 were $73, $1,013 and $708, respectively. Realized losses from the sale of available-for sale marketable securities for 2014, 2013 and 2012 were $12, $4 and $38, respectively. The Company determines realized gains or losses on the sale of available-for-sale marketable securities based on a specific identification method.

Note_4_Other_Accounts_Receivab

Note 4 - Other Accounts Receivable and Prepaid Expenses	12 Months Ended
Note 4 - Other Accounts Receivable and Prepaid Expenses	Dec. 31, 2014
Other Accounts Receivable And Prepaid Expenses Disclosure [Abstract]
Other Accounts Receivable And Prepaid Expenses Disclosure [Text Block]	NOTE 4:-	OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES

			December 31,
			2014		2013
	Prepaid expenses		$	1,010	$	1,706
	Tax and governmental receivables			649		652

	Deposits			208		201
	Others			35		82

			$	1,902	$	2,641

Note_5_Inventories

Note 5 - Inventories	12 Months Ended
Note 5 - Inventories	Dec. 31, 2014
Inventory Disclosure [Abstract]
Inventory Disclosure [Text Block]	NOTE 5:-	INVENTORIES

	Inventories are composed of the following:

			December 31,
			2014		2013

	Work-in-progress		$	6,795	$	5,412
	Finished products			8,840		6,922

			$	15,635	$	12,334

	For the years ended December 31, 2014 and 2013, the Company recorded $6 and $261, respectively, of income due to the utilization of inventory that was previously written off. Inventory write-downs amounted to $29 for the year ended December 31, 2012.

Note_6_Property_and_Equipment

Note 6 - Property and Equipment	12 Months Ended
Note 6 - Property and Equipment	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE 6:-	PROPERTY AND EQUIPMENT, NET

	Composition of assets, grouped by major classifications, is as follows:

			December 31,
			2014		2013
	Cost:
	Computers and equipment		$	17,793	$	40,624
	Office furniture and equipment			1,446		1,590
	Leasehold improvements			4,559		4,651

				23,798		46,865
	Less - accumulated depreciation			20,955		44,028

	Depreciated cost		$	2,843	$	2,837

	During 2014, the Company disposed fully depreciated equipment, which ceased to be used, in the amount of $24,247. No capital loss was recorded due to this disposal of equipment in the consolidated statement of operations.

	Depreciation expenses, which also include amortization expenses of assets recorded under capital leases, amounted to $1,290, $1,994 and $3,168 for the years ended December 31, 2014, 2013 and 2012, respectively.

Note_7_Intangible_Asset_Net

Note 7 - Intangible Asset, Net	12 Months Ended
Note 7 - Intangible Asset, Net	Dec. 31, 2014
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	NOTE 7:-	INTANGIBLE ASSETS, NET

	The following table shows the Company's intangible assets for the periods presented:

			Useful life		December 31,
			(years)		2014		2013

	Cost:
	Current technology			4.2 - 5.3	$	77,080	$	77,080
	Customer relations			7.3		23,477		23,477
	Technology (completion of the development of in-process R&D)			6		7,702		7,702
	Non-competition agreement			3		519		519

						108,778		108,778
	Accumulated amortization:
	Current technology					48,263		48,263
	Customer relations					13,407		13,274
	Technology (completion of the development of in-process R&D)					2,567		1,284
	Non-competition agreement					519		360

						64,756		63,181
	Impairment: (Note 7b)
	Current technology					28,817		28,817
	Customer relations					10,070		10,070

						38,887		38,887

	Amortized cost				$	5,135	$	6,710

		a.	Amortization expenses amounted to $1,573, $1,672 and $2,310 for the years ended December 31, 2014, 2013 and 2012, respectively.

		b.	Estimated amortization expenses for the years ending:

	Year ending December 31,

	2015		$	1,284
	2016			1,284
	2017			1,284
	2018			1,283

			$	5,135

Note_8_Fair_Value_Measurements

Note 8 - Fair Value Measurements	12 Months Ended
Note 8 - Fair Value Measurements	Dec. 31, 2014
Disclosure Text Block [Abstract]
Fair Value, Measurement Inputs, Disclosure [Text Block]	NOTE 8:- FAIR VALUE MEASUREMENTS

	In accordance with ASC 820, the Company measures its cash equivalents, marketable securities and foreign currency derivative contracts at fair value. Cash equivalents, marketable securities and foreign currency derivative contracts are classified within Level 1 or Level 2 value hierarchies. This is because cash equivalents, and marketable securities are valued using quoted market prices or alternative pricing sources and models utilizing market observable inputs. Foreign currency derivative contracts are classified within Level 2 value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments.

	The following table provides information by value level for financial assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2014 (see also Note 3):

		Balance as of			Fair value measurements
	Description	December 31,			Level 1		Level 2			Level 3
	Description	2014			Level 1		Level 2			Level 3

	Assets

	Cash equivalents
	Money market mutual funds	$	2,746		$	2,746		-			-

	Short-term marketable securities and time deposits
	U.S. GSE securities	$	1,499			-	$	1,499			-
	Corporate debt securities	$	7,410			-	$	7,410			-

	Long-term marketable securities
	U.S. GSE securities	$	19,552			-	$	19,552			-
	Corporate debt securities	$	72,717			-	$	72,717			-

	Derivative liabilities	$	(618	)		-	$	(618	)		-

	The following table provides information by value level for financial assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2013:

		Balance as of			Fair value measurements
	Description	December 31,			Level 1		Level 2			Level 3
	Description	2013			Level 1		Level 2			Level 3

	Assets

	Cash equivalents
	Money market mutual funds	$	3,762		$	3,762

	Short-term marketable securities and time deposits
	U.S. GSE securities	$	251				$	251			-
	Corporate debt securities	$	10,733				$	10,733			-

	Long-term marketable securities
	U.S. GSE securities	$	2,831				$	2,831			-
	Corporate debt securities	$	87,331				$	87,331			-

	In addition to the assets and liabilities described above, the Company's financial instruments also include cash and cash equivalents, restricted deposits, short-term deposits, trade receivables, other accounts receivable, trade payables, accrued expenses and other payables. The fair value of these financial instruments was not materially different from their carrying value at December 31, 2014 and 2013 due to the short-term maturity of these instruments.

Note_9_Investment_in_Other_Com

Note 9 - Investment in Other Company	12 Months Ended
	Dec. 31, 2014
Investments, All Other Investments [Abstract]
Cost-method Investments, Description [Text Block]	NOTE 9:-	INVESTMENT IN OTHER COMPANY

	On October 24, 2013, the Company made an investment of $2,200 in a private company in Asia which enables it to expand its reach and presence as well as leverage a base of local professional experts. The investment was in return for approximately 14% of the equity of the company, on a fully diluted basis. The Company also signed a buyout agreement pursuant to which the Company had the option to purchase from all holders of the Asian private company, under agreed terms, all of the remaining outstanding securities by no later than December 31, 2014. The terms and conditions of the above buyout agreement were modified on November 2014 (including an extension of the option to purchase the remaining outstanding securities until December 31, 2015). The investment is accounted under the cost-method in accordance with ASC 325-20.

Note_10_Accrued_Expenses_and_O

Note 10 - Accrued Expenses and Other Accounts Payable	12 Months Ended
Note 10 - Accrued Expenses and Other Accounts Payable	Dec. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE 10:-	ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE

			December 31,
			2014		2013

	Accrued expenses		$	3,279	$	3,324
	Derivative instruments			618		-
	Legal, accounting and investors relation accrual			543		779
	Royalties and commission			538		640
	Others			874		789

			$	5,852	$	5,532

Note_11_Accrued_Pension_Liabil

Note 11 - Accrued Pension Liabilities	12 Months Ended
Note 11 - Accrued Pension Liabilities	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	NOTE 11:-	ACCRUED PENSION LIABILITIES

	As of December 31, 2014 and 2013, the defined benefits plans that the Company assumed in connection with the CIPT Acquisition that are accounted for in the Company's consolidated financial statements are the pension plans in Germany and India. Consistent with the requirements of local law, the Company deposits funds for certain plans with insurance companies, third-party trustees, or into government-managed accounts, and/or accrues for the unfunded portion of the obligation.

	The Company’s pension obligation in Germany relating to the unvested pension claims (i.e. future obligation that will result from future service period) of the employees were outsourced in November 2010 to an external insurance company ("Nuremberger Versicherung"). From and after the outsourcing date, the Company is required to pay premiums to the external insurance company and in return the pension benefits earned by the German employees are covered by the Company’s arrangement with the external insurance company. The Company legally is released from its obligations to the German employees once the premiums are paid, and it is no longer subject to any of the risks and rewards associated with the benefit obligations covered and the plan assets transferred to the external insurance company. Since the outsourcing arrangement meets the requirements of a nonparticipating annuity contract, the Company treats the costs of the outsourcing arrangement as the costs of the benefits being earned in accordance with ASC Paragraph 715-30-25-7 of ASC 715 "Compensation—Retirement Benefits."

	The following tables provide a reconciliation of the changes in the pension plans' benefit obligation and fair value of assets for the years ended December 31, 2014 and 2013, and the statement of funded status as of December 31, 2014 and 2013:

			December 31,
			2014				2013

	Accumulated benefit obligation		$	1,194			$	1,227

	Change in benefit obligation

	Benefit obligation at beginning of year		$	1,239			$	1,334
	Service cost			5				5
	Interest cost			29				35
	Benefits paid from the plan			(152	)			(181	)
	Actuarial loss			218				1
	Exchange rates and others			(134	)			45

	Benefit obligation at end of year		$	1,205			$	1,239

	Change in plan assets

	Fair value of plan assets at beginning of year			258				364
	Actual return on plan assets			6				6
	Employer contributions to plan			-				-
	Benefits paid from the plan			(127	)			(123	)
	Exchange rates			(21	)			11

	Fair value of plan assets at end of year		$	116			$	258

	The assumptions used in the measurement of the Company's pension expense and benefit obligations as of December 31, 2014, 2013 and 2012 are as follows:

			Year ended December 31,
			2014				2013				2012
	Weighted-average assumptions
	Discount rate			2.1	%			3.5	%			3.6	%
	Expected return on plan assets			2.86	%			2.88	%			2.88	%
	Rate of compensation increase			2.5	%			2.5	%			2.5	%

	The amounts reported for net periodic pension costs and the respective benefit obligation amounts are dependent upon the actuarial assumptions used. The Company reviews historical trends, future expectations, current market conditions, and external data to determine the assumptions. The discount rate is determined considering the yield of government bonds. The rate of compensation increase is determined by the Company, based on its long-term plans for such increases.

	The following table provides the components of net periodic benefit cost for the years ended December 31, 2014, 2013 and 2012:

			December 31,
			2014				2013				2012
	Components of net periodic benefit cost

	Service cost		$	5			$	5			$	61
	Interest cost			29				35				47
	Expected return on plan assets			(6	)			(6	)			(12	)
	Amortization of net loss			11				11				2

	Net periodic benefit cost		$	39			$	45			$	98

			December 31,
			2014				2013

	Net amounts recognized in the consolidated balance sheets as of December 31, 2014 and 2013 consist of:
	Current liabilities		$	-			$	-
	Noncurrent liabilities			1,089				981

Net amounts recognized in the consolidated balance sheets		$	1,089			$	981

Net amounts recognized in accumulated other comprehensive income as of December 31, 2014 and 2013 consist of:
Net actuarial loss		$	(435	)		$	(237	)

Net amounts recognized in accumulated other comprehensive loss		$	(435	)		$	(237	)

The estimated amount that will be amortized from accumulated other comprehensive income (loss) into net periodic benefit cost in 2015 is as follows:

		2015

Net actuarial loss and other		$	22

Benefit payments are expected to be paid as follows:

Year ending December 31,

2015		$	104
2016		$	60
2017		$	22
2018		$	9
2019		$	9
2020-2024		$	99

The plan asset allocations at December 31 of the relevant years are as follows:

		December 31,
		2014				2013

Bonds			-				-
Real estate			-				-
Cash			-				-
Shares			-				-
Other			100	%			100	%

			100	%			100	%

The fair value of the Company's pension plan assets at December 31, 2014 by asset category, classified by the three levels of inputs described in Note 2, are as follows:

		Fair value measurements at December 31, 2014 using:

		Total fair				Quoted				Significant				Significant
		value at				prices in				other				unobservable
		December				active				observable				inputs
		31, 2014				markets				inputs				(Level 3)
						(Level 1)				(Level 2)

Cash		$	-			$	-			$	-			$	-
Equity securities			-				-				-				-
Real estate			-				-				-				-
Corporate bonds			-				-				-				-
Others			116				-				116				-

Total assets measured at fair value		$	116			$	-			$	116			$	-

Valuation techniques - For Level 2 inputs, the Company utilizes quoted market prices in markets that are not active, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

Regarding the policy for amortizing actuarial gains or losses for pension and post-employment plans, the Company has chosen the "corridor" option. This option consists of recognizing in the consolidated statements of operations, the part of unrecognized actuarial gains or losses exceeding 10% of the greater of the PBO or the market value of the plan assets. If amortization is required, the minimum amortization amount is that excess divided by the average remaining service period of the active employees expected to receive benefits under the plan.

Actuarial losses were recognized in other comprehensive income (loss) in the amount of $209, $11 and $160 for the years ended December 31, 2014, 2013 and 2012, respectively.

Note_12_Financial_Income_Net

Note 12 - Financial Income, Net	12 Months Ended
Note 12 - Financial Income, Net	Dec. 31, 2014
Disclosure Text Block [Abstract]
Other Nonoperating Income and Expense [Text Block]	NOTE 12:-	FINANCIAL INCOME, NET

	The components of financial income, net were as follows:

			Year ended December 31,
			2014		2013		2012

	Foreign exchange gains		$	27	$	-	$	120
	Interest income from marketable securities and deposits, net of amortization of premium on marketable securities			1,391		1,656		1,859
	Realized gains on marketable securities			73		1,013		708
	Other			-		13		1

	Financial income			1,491		2,682		2,688

	Realized losses on marketable securities			12		4		38
	Foreign exchange losses			113		86		88
	Interest expenses			24		29		35
	Other			138		106		139

	Financial expense			287		225		300

	Financial income, net		$	1,204	$	2,457	$	2,388

Note_13_Stockholders_Equity

Note 13 - Stockholders' Equity	12 Months Ended
Note 13 - Stockholders' Equity	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE 13:-	STOCKHOLDERS' EQUITY

		a.	Preferred stock:

	The Company's Board of Directors has the authority, without any further vote or action by the stockholders, to provide for the issuance of up to 5,000,000 shares of preferred stock in one or more series with such designations, rights, preferences, and limitations as the Board of Directors may determine, including the consideration received, the number of shares comprising each series, dividend rates, redemption provisions, liquidation preferences, sinking fund provisions, conversion rights and voting rights. No shares of preferred stock are currently outstanding.

		b.	Common Stock:

	Currently, 50,000,000 shares of common stock are authorized. Holders of common stock are entitled to one vote per share on all matters to be voted upon by the Company's stockholders. Subject to the rights of holders of preferred stock, if any, in the event of liquidation, dissolution or winding up, holders of common stock are entitled to share ratably in all of the Company's assets. The Company's Board of Directors may declare a dividend out of funds legally available therefore and, subject to the rights of holders of preferred stock, if any, the holders of common stock are entitled to receive ratably any such dividends.

	Holders of common stock have no preemptive rights or other subscription rights to convert their shares into any other securities. There are no redemption or sinking fund provisions applicable to common stock.

		c.	Dividend policy:

	At December 31, 2014, the Company had an accumulated deficit of $85,352. The Company has never paid cash dividends on the common stock and presently intends to follow a policy of retaining earnings for reinvestment in its business.

		d.	Share repurchase program:

	In November 2013, the Company entered into a share repurchase plan, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, for the repurchase of up to 2,700,000 shares of its common stock. This amount is in addition to the approximately 308,000 shares that were available for repurchase under the board’s prior authorizations.

	In 2014, 2013 and 2012, the Company repurchased approximately 1,414,000, 390,000 and 1,283,000 shares, respectively, of common stock at an average purchase price of $8.83, $8.95 and $6.28 per share, respectively, for an aggregate purchase price of $12,484, $3,490 and $8,060, respectively. As of December 31, 2014, 1,203,601 shares of the Company’s common stock remained authorized for repurchase under the Company's board-authorized share repurchase program.

	In 2014, 2013 and 2012, the Company issued 908,000, 1,066,000 and 455,000 shares, respectively, of common stock, out of treasury stock, to employees who exercised their equity awards under the Company's equity incentive plans or purchased shares from the Company's 1993 Employee Stock Purchase Plan ("ESPP").

		e.	Stock purchase plan and equity incentive plans:

	The Company has various equity incentive plans under which employees, officers, non-employee directors of the Company and its subsidiaries and others, including consultants, may be granted rights to purchase the Company's common stock. The plans authorize the administrator, except for the grant of RSUs, to grant equity incentive awards at an exercise price of not less than 100% of the fair market value of the common stock on the date the award is granted. It is the Company's policy to grant stock options and SARs at an exercise price that equals the fair market value

	Equity awards granted under all stock incentive plans that are cancelled or forfeited before expiration become available for future grant.

	During 2012 and 2011, the Company granted to employees and executive officers of the Company primarily share appreciation rights ("SARs"), capped with a ceiling, under the various equity incentive plans. The SAR unit confers the holder the right to stock appreciation over a preset price of the Company's common stock during a specified period of time. When the unit is exercised, the appreciation amount is paid through the issuance of shares of the Company's common stock. The ceiling limits the maximum income for each SAR unit and the maximum number of shares to be issued. SARs are considered an equity instrument as it is a net share settled award capped with a ceiling.

	Starting in 2013, the Company granted to employees and executive officers of the Company primarily restricted stock units (“RSUs”) under the various equity incentive plans. An RSU award is an agreement to issue shares of our common stock at the time the award is vested. RSUs granted to employees and executive officers generally vest over a four year period from the grant date with 25% of the RSUs granted vesting on the first anniversary of the grant date and 6.25% vesting each quarter thereafter.

	A summary of the various plans is as follows:

	1993 Director Stock Option Plan

	Upon the closing of the Company's initial public offering, the Company adopted the 1993 Director Stock Option Plan (the "Directors Plan"). Under the Directors Plan, which expired in January 2014, the Company was authorized to issue nonqualified stock options to the Company's outside non-employee directors to purchase up to 1,980,875 shares of common stock at an exercise price equal to the fair market value of the common stock on the date of grant. The Directors Plan, as amended, provided that each person who became an outside, non-employee director of the Board of Directors was automatically granted an option to purchase 30,000 shares of common stock (the "First Option"). Thereafter, each outside director was automatically granted an option to purchase 15,000 shares of common stock (a "Subsequent Option") on January 1 of each year if, on such date, he had served on the Board of Directors for at least six months. In addition, an option to purchase an additional 15,000 shares of common stock (a "Committee Option") was granted on January 1 of each year to each outside director for each committee of the Board on which had served as a chairperson for at least six months.

	Options granted under the Directors Plan generally had a term of 10 years. One-third of the shares were exercisable after the first year and thereafter one-third at the end of each twelve-month period.

	The Directors Plan expired in January 2014 and therefore no further awards may be granted thereunder. As of December 31, 2014, 2,464,933 shares of common stock had been granted under the plan and stock options to acquire 540,000 shares remained outstanding in the plan prior to its expiration.

	1998 Non-Officer Employee Stock Option Plan

	In 1998, the Company adopted the 1998 Non-Officer Employee Stock Option Plan (the "1998 Plan"). Under the 1998 Plan, employees may be granted non-qualified stock options for the purchase of common stock. The 1998 Plan currently provides for the purchase of up to 5,062,881 shares of common stock. As of December 31, 2014, 118,535 shares of common stock remained available for grant under the 1998 Plan.

	The exercise price of options under the 1998 Plan shall not be less than the fair market value of common stock for nonqualified stock options, as determined by the Company's Board of Directors or a committee appointed by the Company's Board of Directors.

	Options under the 1998 Plan are generally exercisable over a 48-month period beginning 12 months after issuance, or as determined by the Company's Board of Directors or a committee appointed by the Company's Board of Directors. Options under the 1998 Plan expire up to seven years after the date of grant.

	2001 Stock Incentive Plan

	In 2001, the Company adopted the 2001 Stock Incentive Plan (the "2001 Plan"). The 2001 Plan expired in 2011 and no further grants of awards may be made thereunder. As of December 31, 2014, 2,194,847 shares of common stock were granted under the plan, stock options to acquire 10,000 shares remained outstanding in the plan prior to its expiration.

	The 2001 Plan authorized the administrator to grant incentive stock options at an exercise price of not less than 100% of the fair market value of the common stock on the date the option is granted.

	Equity awards under the 2001 Plan were generally exercisable over a 48-month period beginning 12 months after issuance or as determined by the Company's Board of Directors or a committee appointed by the Company's Board of Directors. Equity awards under the 2001 plan expired up to seven years after the date of grant.

	2003 Israeli Share Incentive Plan

	In 2003, the Company adopted the 2003 Israeli Share Incentive Plan (the "2003 Plan"), which complied with the Israeli tax reforms. The 2003 Plan terminated in 2012 upon approval of the Company's 2012 Equity Incentive Plan (the "2012 Plan"). As of December 31, 2014, 10,700,543 shares of common stock had been granted under the plan and stock option and SARs to acquire 1,412,613 shares of common stock remained outstanding under the plan. As the 2003 Plan expired in May 2012, no further awards may be granted thereunder.

Equity awards under the 2003 Plan were generally exercisable over a 48-month period beginning 12 months after issuance, or as determined by the Company's Board of Directors or a committee appointed by the Company's Board of Directors. Equity awards under the 2003 Plan expired up to seven years after the date of grant.

2012 Equity Incentive Plan

In 2012, the Company adopted the 2012 Plan, which also complies with the Israeli tax reforms. Under the 2012 Plan, employees, directors and consultants may be granted incentive or non-qualified stock options, SARs, RSUs and other awards under the plan. The exercise price of the equity awards under the 2012 Plan shall not be less than the fair market value of common stock at the time of grant, unless otherwise determined by the Company's Board of Directors or a committee appointed by the Company's Board of Directors. The 2012 Plan currently provides for the purchase of up to 1,450,000 shares of common stock. As of December 31, 2014, 475,435 shares of common stock remained available for grant under the 2012 Plan.

Stock options, SARs and RSUs awarded under the 2012 Plan to employees and executive officers are generally exercisable over a 48-month period beginning 12 months after issuance, or as determined by the Company's Board of Directors or a committee appointed by the Company's Board of Directors Equity awards under the 2012 Plan expire up to seven years after the date of grant.

A director subplan was established under the 2012 Plan to provide for the grant of equity awards to the Company’s non-employee directors. The director subplan is designed to work automatically; however, to the extent administration is necessary, it would be provided by the Company’s board of directors. Starting in 2014, non-employee directors are granted automatically under the director subplan, on January 1 of each year, 8,000 stock options and 4,000 restricted stock units, all of which would fully vest at the end of one year from the grant date. If a director is appointed for a term commencing during a calendar year, the director would be granted stock options and restricted stock units on the date of appointment and the number of stock options and restricted stock units granted would be based upon the number of days remaining in the in the calendar year following the date such person was nominated as a director. Solely with respect to calendar year 2014, in addition to the grants of 8,000 stock options and 4,000 restricted stock units on January 1, 2014 to all then elected board members, each committee chair also received an automatic grant of stock options of 15,000 shares.

1993 Employee Stock Purchase Plan (ESPP)

Upon the closing of the Company's initial public offering, the Company adopted the ESPP. The Company has reserved an aggregate of 3,800,000 shares of common stock for issuance under the ESPP. The ESPP provides that substantially all employees of the Company may purchase Company common stock at 85% of its fair market value on specified dates via payroll deductions. There were approximately 310,000, 374,000 and 446,000 shares of common stock issued at a weighted average purchase price of $5.55, $4.44 and $4.42 per share under the ESPP in 2014, 2013 and 2012, respectively. As of December 31, 2014, 403,000 shares of common stock were reserved under the ESPP.

Stock Reserved for Future Issuance

The following table summarizes the number of shares available for future issuance at December 31, 2014 (after giving effect to the above increases in the equity incentive plans):

ESPP			403,000
Equity awards			594,000
Undesignated preferred stock			5,000,000

			5,997,000

The following is a summary of activities relating to the Company's stock options, SARs and RSUs granted among the Company's various plans:

		Year ended December 31,
		2014									2013							2012
		Amount of			Weighted			Aggregate			Amount of			Weighted		Aggregate		Amount of			Weighted		Aggregate
		options/			average			intrinsic			options/			average		intrinsic		options/			average		intrinsic
		SARs/RSUs			exercise price			value (4)			SARs/RSUs			exercise price		value (4)		SARs/RSUs			exercise price		value (4)
		in thousands									in thousands							in thousands

Options outstanding at beginning of year			6,537		$	8.68		$	-			9,622		$	10.72	$	-		10,564		$	12.22	$	-
Changes during the year:
Options granted			232		$	9.15		$	-			524		$	6.42	$	-		310		$	5.67	$	-
SARs granted (1)			-		$	-		$	-			-		$	-	$	-		1,100		$	6.16	$	-
RSUs granted			337		$	-		$	-			552		$	-	$	-		-		$	-	$	-
Exercised			(1,715	)	$	7.92		$	3,537			(2,105	)	$	6.49	$	3,795		(127	)	$	5.97	$	62

Forfeited and cancelled			(747	)	$	20.11		$	-			(2,056	)	$	17.56	$	-		(2,225	)	$	15.14	$	-

Options/SARs/RSUs outstanding at end of year (2)			4,644		$	6.52		$	21,409			6,537		$	8.68	$	16,673		9,622		$	10.72	$	98

Options/SARs/RSUs exercisable at end of year (3)			3,106		$	7.73		$	10,941			4,623		$	10.3	$	7,230		7,223		$	12.07	$	28

-1	SAR grants made prior to January 1, 2009 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SAR units subject to the grant. SAR grants made on or after January 1, 2009 and before January 1, 2010 are convertible for a maximum number of shares of the Company's common stock equal to 75% of the SAR units subject to the grant. SAR grants made on or after January 1, 2010 are convertible for a maximum number of shares of the Company's common stock equal to 66.67% of the SAR units subject to the grant. SAR grants made on or after January 1, 2012 are convertible for a maximum number of shares of the Company’s common stock equal to 50% of the SAR units subject to the grant.

-2	Due to the ceiling imposed on the SAR grants, the outstanding amount above can be exercised for a maximum of 3,670,000 shares of the Company's common stock as of December 31, 2014.

-3	Due to the ceiling imposed on the SAR grants, the exercisable amount above can be exercised for a maximum of 2,279,000 shares of the Company's common stock as of December 31, 2014.

-4	Calculation of aggregate intrinsic value for options, RSUs and SARs outstanding and exercisable is based on the share price of the Company's common stock as of December 31, 2014, 2013 and 2012 which was $10.87, $9.71 and $5.76 per share, respectively. The intrinsic value for options and SARs exercised during those years represents the difference between the fair market value of the Company's common stock on the date of exercise and the exercise price of each option or SAR, as applicable.

The stock options and SARs outstanding as of December 31, 2014, have been separated into ranges of exercise price as follows:

Range of		Outstanding			Remaining			Weighted			Exercisable			Remaining		Weighted
exercise					contractual			average						contractual		average
price					life (years)			exercise						life (years)		exercise
					-1			price								price
$		thousands							$		thousands						$

0 (RSUs)			660			-			-			-			-		-
5.21-7.26			2,484			3.39			6.46			1,941			2.93		6.55
7.49-10.23			1,345			3.71			8.44			1,010			2.54		8.33
11.60-15.79			65			1.89			12.52			65			1.89		12.52
21.07-25.06			90			1			23.03			90			1		23.03

			4,644			3.42			6.52			3,106			2.73		7.73

	-1	Calculation of weighted average remaining contractual term does not include the RSUs that were granted, which have an indefinite contractual term.

As of December 31, 2014, the outstanding number of SARs was 2,468,499 and based on the share price of the Company's common stock as of December 31, 2014 ($10.87 per share), 2,451,499 of those SARs were in the money as of December 31, 2014.

The weighted average estimated fair value of employee RSUs granted during 2014 was 7.94 per share (using the weighted average pre vest cancellation rate of 3.79% on an annual basis).

The weighted-average estimated fair value of employee stock options and SARs granted during the years ended December 31, 2014, 2013 and 2012 was $3.47, $4.90 and $2.39 per stock option and SAR, respectively, using the binomial model with the following weighted-average assumptions (annualized percentages):

		Year ended December 31,
		2014			2013			2012

Volatility			43.14	%		46.24	%		48.23	%
Risk-free interest rate			1.85	%		1.39	%		2.2	%
Dividend yield			0	%		0	%		0	%
Pre-vest cancellation rate *)			4.17	%		3.48	%		3.5	%
Post-vest cancellation rate **)			4.09	%		2.52	%		2.58	%
Suboptimal exercise factor ***)			1.61			1.81			1.6
Expected life (years)			3.27			4.66			4.19

	*)	The pre-vest cancellation rate was calculated on an annual basis and is presented here on an annual basis.

	**)	The post-vest cancellation rate was calculated on a monthly basis and is presented here on an annual basis.

	***)	The ratio of the stock price to strike price at the time of exercise of the option.

The computation of volatility uses a combination of historical volatility and implied volatility derived from the Company's exchange traded options with similar characteristics.

The risk-free interest rate assumption is based on U.S. treasury bill interest rates appropriate for the term of the Company's employee equity-based awards.

The dividend yield assumption is based on the Company's historical and expectation of future dividend payouts and may be subject to substantial change in the future.

The expected term of employee equity-based awards represents the weighted-average period the awards are expected to remain outstanding and is a derived output of the binomial model. The expected life of employee equity-based awards is impacted by all of the underlying assumptions used in the Company's model. The binomial model assumes that employees' exercise behavior is a function of the award's remaining contractual life and the extent to which the award is in-the-money (i.e., the average stock price during the period is above the strike price of the award). The binomial model estimates the probability of exercise as a function of these two variables based on the history of exercises and cancellations on past award grants made by the Company.

As equity-based compensation expense recognized in the consolidated statement of operations is based on awards ultimately expected to vest, it should be reduced for estimated forfeitures. The forfeitures are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

Pre and post-vesting forfeitures were estimated based on historical experience.

The fair value for rights to purchase shares of common stock under the Company's ESPP was estimated on each enrollment date using the same assumptions set forth above for the years ended 2014, 2013 and 2012 except the expected life and the volatility. The expected life was assumed to be between six to 24 months based on the contractual life of the plan, and the expected volatility was assumed to be in a range of 29.06%-37.17% in 2014, 36.37%-44.19% in 2013 and 35.79%-42.02% in 2012.

The Company's aggregate equity compensation expenses for the years ended December 31, 2014, 2013 and 2012 totaled $5,359, $4,159 and $4,983, respectively. The Company recognized no tax benefit in its consolidated statements of operations for the years ended December 31, 2014, 2013 and 2012 for the Company's equity-based compensation arrangements.

A summary of the status of the Company's non-vested stock options, SARs and RSUs as of December 31, 2014, and changes during the year ended December 31, 2014, is presented below:

Non-vested		Units			Weighted average
					grant date fair
					value
		(In thousands)

Non-vested at January 1, 2014			1,914			4.14

Granted			569			6.12
Vested			(918	)		3.89
Forfeited			(27	)		4.26

Non-vested at December 31, 2014			1,538			5.01

As of December 31, 2014, equity-based compensation arrangements to purchase a maximum of approximately 3,376,000 shares of common stock were vested and expected to vest (the calculation takes into consideration the forfeiture rate).

As of December 31, 2014, there was a total unrecognized compensation expense of $3,168 related to non-vested equity-based compensation arrangements granted under the Company's various equity incentive plans. That expense is expected to be recognized during the period from 2015 through 2018.

Note_14_Commitments_and_Contin

Note 14 - Commitments and Contingencies	12 Months Ended
Note 14 - Commitments and Contingencies	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	NOTE 14:-	COMMITMENTS AND CONTINGENCIES

	Commitments

		a.	The Company and its subsidiaries lease certain equipment and facilities under non-cancelable operating leases. The Company has significant leased facilities in Herzlia Pituach, Israel. The lease agreement for the Israeli facilities is effective until November 2018. The Company has various agreements for its facilities in the U.S. that terminate in 2015 through 2016. The Company's subsidiaries in Scotland, Japan, Germany, China and Hong-Kong have lease agreements for their facilities that terminate in 2019, 2017, 2016, 2016 and 2016, respectively. The Company's subsidiary in India has sublease agreements with NXP for their facilities that terminate in 2017. The Company has operating lease agreements for its motor vehicles which terminate in 2015 through 2017.

	At December 31, 2014, the Company is required to make the following minimum lease payments under non-cancelable operating leases for motor vehicles and facilities:

	Year ended December 31,

	2015		$	2,977
	2016			2,584
	2017			1,687
	2018 and thereafter			1,360

			$	8,608

	Facilities rental expenses amounted to $2,298, $2,389 and $2,891 for the years ended December 31, 2014, 2013 and 2012, respectively.

		b.	The Company participated in programs (most of which are royalty bearing grants) sponsored by the Israeli government for the support of research and development activities. Through December 31, 2014, the Company had obtained grants from the Israeli Office of the Chief Scientist (the “OCS”) for certain of the Company’s research and development projects. The Company is obligated to pay royalties to the OCS, amounting to 5% of the sales of the products and other related revenues (based on the dollar) generated from such projects, up to 100% of the grants received. The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required.

	As of December 31, 2014, the aggregate contingent liability to the OCS amounted to $5,290. The Israeli Research and Development Law provides that know-how developed under an approved research and development program may not be transferred to third parties without the approval of the OCS. Such approval is not required for the sale or export of any products resulting from such research or development. The OCS, under special circumstances, may approve the transfer of OCS-funded know-how outside Israel, in the following cases: (a) the grant recipient pays to the OCS a portion of the sale price paid in consideration for such OCS-funded know-how or in consideration for the sale of the grant recipient itself, as the case may be, which portion will not exceed six times the amount of the grants received plus interest (or three times the amount of the grant received plus interest, in the event that the recipient of the know-how has committed to retain the R&D activities of the grant recipient in Israel after the transfer); (b) the grant recipient receives know-how from a third party in exchange for its OCS-funded know-how; (c) such transfer of OCS-funded know-how arises in connection with certain types of cooperation in research and development activities; or (d) if such transfer of know-how arises in connection with a liquidation by reason of insolvency or receivership of the grant recipient.

	Litigation

		a.	The Company is involved in certain claims arising in the normal course of business. However, the Company believes that the ultimate resolution of these matters will not have a material adverse effect on its financial position, results of operations, or cash flows.

		b.	From time to time, the Company may become involved in litigation relating to claims arising in the ordinary course of business activities. Also, as is typical in the semiconductor industry, the Company has been and, from time to time may be, notified of claims that it may be infringing on patents or intellectual property rights owned by third parties.

Note_15_Taxes_On_Income

Note 15 - Taxes On Income	12 Months Ended
Note 15 - Taxes On Income	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE 15:-	TAXES ON INCOME

		a.	The provision for income taxes is as follows:

			Year ended December 31,
			2014				2013			2012
	Domestic taxes

	Federal taxes:
	Current		$	-			$	(271	)	$	(465	)

	State taxes:
	Current			2				(9	)		1

	Foreign taxes:
	Current (1)			(1,672	)			507			304
	Deferred (2)			(1,170	)			(377	)		(12	)

				(2,842	)			130			292

	Income tax benefit		$	(2,840	)		$	(150	)	$	(172	)

		-1	Includes (i) income in the amount of $858 due to reversal of income tax contingency reserves that were determined to be no longer needed due to finalization of a tax assessment of one of the Company’s subsidiaries and (ii) income in the amount of $1,234 due to removal of valuation allowance of tax advances.

		-2	Includes income tax benefit in the amount of $827 due to elimination of valuation allowance of deferred tax assets.

	There were no tax benefits associated with the exercise of non-qualified stock options in 2014, 2013 and 2012.

		b.	Income (loss) before taxes is comprised as follows:

			Year ended December 31,
			2014				2013			2012

	Domestic		$	(3,497	)		$	(3,525	)	$	(844	)
	Foreign			4,258				6,051			(7,370	)

			$	761			$	2,526		$	(8,214	)

		c.	A reconciliation between the Company's effective tax rate assuming all income is taxed at statutory tax rate applicable to the income of the Company and the U.S. statutory rate is as follows:

			Year ended December 31,
			2014				2013			2012


	Income (loss) before taxes on income		$	761			$	2,526		$	(8,214	)

	Theoretical tax at U.S. statutory tax rate (35%)		$	266			$	884		$	(2,875	)
	State taxes, net of federal benefit			2				2			2
	Foreign income taxed at rates other than the U.S. rate (including deferred taxes that were not provided, valuation allowance and current adjustment and interest on uncertain tax position liability)			(5,974	)			(3,015	)		1,253
	Nondeductible equity-based compensation expenses			1,876				1,456			1,744
	Current adjustment and interest on uncertain tax position liability in U.S.			-				(283	)		(465	)
	Valuation allowance in U.S.			989				804			154
	Other			1				2			15

			$	(2,840	)		$	(150	)	$	(172	)

		d.	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.

			December 31,
			2014				2013

	Deferred tax assets (short-term):

	Reserves and accruals		$	149			$	92
Carryforward tax losses		$	626			$	-

Total deferred tax assets (short-term)			775				92
Valuation allowance			-				-

Total			775				92

Deferred tax assets (long-term):

Reserves and accruals			1,669				1,074
Equity-based compensation			2,761				2,526
Intangible assets			1,198				1,453
Carryforward tax losses			27,621				31,817
Other			15				16

Total deferred tax assets (long-term)			33,264				36,886
Valuation allowance			(33,115	)			(36,886	)

Total			149				-

Total deferred tax assets		$	924			$	92

Deferred tax liabilities, net (Long term):
Acquired intangible assets			1,360				1,670
Acquired carryforward tax losses			(515	)			(487	)

Total deferred tax liabilities, net		$	845			$	1,183

Management believes that part of the deferred tax assets will not be realized based on current levels of future taxable income and potentially refundable taxes. Accordingly, a valuation allowance in the amount of $33,115 and $36,886 was provided as of December 31, 2014 and 2013, respectively. As of December 31, 2014, the Company had cash and cash equivalents, marketable securities and time deposits of approximately $124.3 million, of which $108.8 million was held by foreign subsidiaries of the Company. The Company intends to permanently reinvest earnings of its foreign operations and its current operating plans do not demonstrate a need to repatriate foreign earnings to fund the Company’s U.S. operations. However, if these funds were needed for the Company’s operations in the United States, the Company would be required to accrue and pay U.S. taxes as well as taxes in other countries to repatriate these funds. The determination of the amount of additional taxes related to the repatriation of these earnings is not practicable, as it may vary based on various factors such as the location of the cash and the effect of regulation in the various jurisdictions from which the cash would be repatriated.

	e.	Uncertain tax positions:

A reconciliation of the beginning and ending balances of the total amounts of gross unrecognized tax benefits is as follows:

		2014				2013

Gross unrecognized tax benefits at January 1		$	1,892			$	1,815
Decrease in tax positions for previous years			(104	)			-
Increases in tax positions for previous years			115				59
Increases in tax positions for current year			71				109
Change in interest and linkage related to tax positions			(85	)			193
Lapse in statute of limitations or finalization of tax assessment			(858	)			(284	)

Gross unrecognized tax benefits at December 31		$	1,031			$	1,892

The total amount of net unrecognized tax benefits that, if recognized, would affect the effective tax rate was $1,031 and $1,892 at December 31, 2014 and 2013, respectively. The Company accrues interest and penalties relating to unrecognized tax benefits in its provision for income taxes. At December 31, 2014 and 2013, the Company had accrued interest and penalties related to unrecognized tax benefits of $135 and $408, respectively.

The Company reversed income tax contingency reserves that were determined to be no longer required due to the expiration of applicable statute of limitations. Pursuant to this reversal, the Company recorded a tax benefit of $284 and $622 during 2013 and 2012, respectively. During 2014, the Company recorded a tax benefit of $858 due to the finalization of tax assessment.

The Company and certain of its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The last examination conducted by U.S. tax authorities was with respect to the Company's U.S. federal income tax returns for 2004. The statute of limitations relating to the consolidated Federal income tax return is closed for all tax years up to and including 2010.

The last examination conducted by the Israeli tax authorities was with respect to the Company’s Israeli income tax returns for the years between 2006 and 2012.

With respect to DSP Israel, the tax returns up to and including 2012 are considered to be final and not subject to any audits due to the expiration of the statute of limitations.

With respect to the Company's Swiss subsidiary, the statute of limitations related to its tax returns is opened for all tax years since its incorporation.

A change in the amount of unrecognized tax benefit is reasonably possible in the next 12 months due to the examination by the German tax authorities of the Company’s German tax returns for 2007 – 2009. The Company currently cannot provide an estimate of the range of change in the amount of the unrecognized tax benefits due to the ongoing status of the examination.

	f.	Tax benefits under the Law for the Encouragement of Capital Investments, 1959 ("Investment Law"): Six separate investment programs of DSP Israel's production facilities have been granted "Approved Enterprise" status and two investment programs of DSP Israel's production facilities were filed under "Beneficiary Enterprise" status under the Investment Law. The Investment Law provides certain Israeli tax benefits for eligible capital investments in a production facility, as discussed in greater detail below.

On April 1, 2005, an amendment to the Investment Law came into effect (the "Amendment") and significantly changed the provisions of the Investment Law. Generally, DSP Israel's investment programs that obtained approval for Approved Enterprise status prior to enactment of the Amendment will continue to be subject to the old provisions of the Investment Law.

The Amendment enacted major changes in the manner in which tax benefits are awarded under the Investment Law so that companies are no longer required to get the Investment Center's prior approval to qualify for tax benefits. An enterprise that receives tax benefits without the initial approval from the Investment Center is called a "Beneficiary Enterprise," rather than the previous terminology of “Approved Enterprise”. The period of tax benefits for a new Beneficiary Enterprise commences in the "Year of Commencement," which is the later of: (1) the year in which taxable income is first generated by the company, or (2) the year of election.

In addition, under the Amendment, tax benefits are available to production facilities, which generally are required to derive more than 25% of their business income from export. Furthermore, in order to receive the tax benefits under the Amendment, a company must make an investment in the Benefited Enterprise exceeding a certain percentage or a minimum amount specified in the Investment Law.

DSP Israel has chosen the "alternative benefits" track for all of its investment programs. Accordingly, DSP Israel's income from an "Approved Enterprise" and "Beneficiary Enterprise" is tax-exempt for a period of two or four years and is subject to a reduced corporate tax rate of 10%-25% (based on the percentage of foreign ownership) for an additional period of eight or six years, respectively.

DSP Israel's first, second, third, fourth, fifth and sixth investment programs, which were completed and commenced operations in 1994, 1996, 1998, 1999, 2002 and 2004, respectively, were tax exempt for a period of between two and four years, from the first year they had taxable income and were entitled to a reduced corporate tax rate of 10%-25% (based on the percentage of foreign ownership) for an additional period of between six to eight years. As of 2014, all those investment programs were no longer entitled to a reduced corporate tax rate.

DSP Israel's seventh and eighth investment programs have been in operation since 2006 and 2009, respectively, and entitles DSP Israel to a corporate tax exemption for a period of two years and a reduced corporate tax rate of 10%-25% (based on the percentage of foreign ownership) for an additional period of eight years from the first year it has taxable income.

Since DSP Israel is operating under more than one approval, its effective tax rate is the result of a weighted combination of the various applicable tax rates and tax exemptions and the computation is made for income derived from each investment program on the basis and formulas specified in the Investment Law and the approvals.

During 2006, DSP Israel received an approval for the erosion of tax basis in respect to its fifth and sixth investment programs. During 2008, DSP Israel received an approval for the erosion of tax basis with respect to its second, third and fourth investment programs. Those approvals resulted in increasing the taxable income attributable to the later investment programs, which are currently in operation and will be taxed at a lower tax rate than the previous investment programs, which in turn will decrease the overall effective tax rate.

The Company's investment programs that generate taxable income are currently subject to an average tax rate of up to approximately 10% based on a variety of factors, including percentage of foreign ownership and approvals for the erosion of the tax basis of our investment programs. The Company's average tax rate for its investment programs may change in the future due to circumstances outside of its control and therefore, the Company cannot provide any assurances that its average tax rate for its investment programs will continue at an approximate rate of 10% in the future.

In December 2010, the Israeli Parliament passed the Law for Economic Policy for 2011 and 2012 (Amended Legislation), which, among other things, included an amendment to the Investment Law, effective as of January 1, 2011 (the “2011 Amendment”). In accordance with the 2011 Amendment, the benefit tracks under the Investment Law were modified and a uniform tax rate would apply to companies eligible for the “Preferred Enterprise” status (rather than the previous terminology of “Beneficiary Enterprise”). Companies may elect to irrevocably implement the 2011 Amendment (while waiving benefits provided under the Investment Law as then in effect).

On July 30, 2013, the Israeli Parliament passed a law, which, among other things, was designated to amend the uniform tax rates that were set in the 2011 Amendment, and to increase the tax levy for years 2013 and 2014 (the “New Law”). The New Law increased the Israeli corporate tax rate from 25% to 26.5%, canceled the reduction of corporate tax rate for “Preferred Enterprises,” which was set on 16% for 2014 and thereafter under the New Law and increased the tax rate on dividends from sources under the Israeli Investment Law to 20% commencing on January 1, 2014.

The Company does not currently intend to implement the 2011 Amendment, rather it intends to continue to comply with the Investment Law as it was in effect prior to enactment of the 2011 Amendment until the earlier of such time that compliance with the Investment Law prior to enactment of the 2011 Amendment is no longer in the Company’s best interests or until the expiration of its current investment programs. The Company is required to comply with the 2011 Amendment subsequent to the expiration of the Company’s current investment programs and for any new qualified investment program after a transitional period. Once the Company is required to comply with the provisions under the 2011 Amendment, its average tax rate may increase.

As of December 31, 2014, DSP Israel believed that it met all the conditions required under the plans, which include inter-alia an obligation to invest certain amounts in property and equipment and an obligation to finance a percentage of investments by share capital.

Should DSP Israel fail to meet such conditions in the future, it could be subject to corporate tax in Israel at the standard tax rate (25% for 2013 and 26.5% for 2014) plus a consumer price index linkage adjustment and interest and could be required to refund tax benefits already received.

As of December 31, 2014, approximately $33,293 was derived from tax exempt profits earned by DSP Israel's "Approved Enterprises" and "Beneficiary Enterprise". The Company has determined that such tax-exempt income will not be distributed as dividends and intends to reinvest the amount of its tax exempt income earned by DSP Israel. Accordingly, no provision for deferred income taxes has been provided on income attributable to DSP Israel's "Approved Enterprises" and "Beneficiary Enterprise" as such income is essentially permanently reinvested.

If DSP Israel's retained tax-exempt income is distributed, the income would be taxed at the applicable corporate tax rate (currently 10%) as if it had not elected the alternative tax benefits under the Investment Law and an income tax liability of approximately $3,699 would have been incurred as of December 31, 2014.

DSP Israel's income from sources other than the "Approved Enterprises" and "Beneficiary Enterprise" during the benefit period will be subject to tax at the effective standard corporate tax rate in Israel (26.5% for 2014).

	g.	Tax benefits under Israel's Law for Encouragement of Industry (Taxation), 1969:

DSP Israel is an "industrial company" under the Law for the Encouragement of Industry (Taxation), 1969, and as such is entitled to certain tax benefits, mainly the amortization of costs relating to know-how and patents, over eight years and accelerated depreciation.

The following corporate tax benefits, among others, are available to Industrial Companies:

•amortization of the cost of purchasing a patent, rights to use a patent and know-how, which are used for the development or advancement of the company, over an eight-year period commencing on the year in which such rights were first exercised;
• under limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and
• expenses related to a public offering are deductible in equal amounts over three years.


Eligibility for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority.

There can be no assurances that the Company will continue to qualify as an Industrial Company or that the benefits described above will be available in the future.

	h.	Israeli tax rates:

The rate of the Israeli corporate tax is as follows: 2012 and 2013 – 25%, 2014 – 26.5%. Tax at a rate of 25% applies on capital gains arising after January 1, 2003.

	i.	In connection with the CIPT Acquisition, the Company received a tax ruling from the Swiss tax authorities with respect to the taxable income generated by its Swiss subsidiary, including the amortization period for tax purposes of goodwill and all other intangible assets acquired in the CIPT Acquisition by its Swiss subsidiary. Pursuant to the tax ruling, the Company's Swiss subsidiary is entitled to reduced tax rates of approximately 10% to 15%, depending on the source of income, and tax amortization period of up to 10 years for the goodwill and other intangible assets acquired in the CIPT Acquisition by its Swiss subsidiary.

	j.	The Company has accumulated losses for federal and state tax purposes as of December 31, 2014 of approximately $12,012 and $2,515, respectively, which may be carried forward and offset against future taxable income for a period of fifteen to twenty years from its creation. DSP Israel has accumulated losses for tax purposes as of December 31, 2014, of approximately $24,236 (including research and development expenses carry forward), which may be carried forward and offset against future taxable income for an indefinite period. The Swiss subsidiary has accumulated losses for tax purposes as of December 31, 2014, of approximately $215,450, which may be carried forward and offset against future taxable income for a period of seven years from its creation.

Note_16_Basic_and_Diluted_Loss

Note 16 - Basic and Diluted Loss Per Share	12 Months Ended
Note 16 - Basic and Diluted Loss Per Share	Dec. 31, 2014
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE 16:- BASIC AND DILUTED LOSS PER SHARE

	The following table sets forth the computation of basic and diluted net loss per share:

		Year ended December 31,
		2014		2013		2012
	Numerator:

	Net income (loss)	$	3,602	$	2,676	$	(8,042	)

	Denominator:

	Weighted average number of shares of common stock outstanding during the year used to compute basic net income (loss) per share (in thousands)		21,968		22,249		21,950

	Incremental shares attributable to exercise of outstanding options, SARs and RSUs (assuming proceeds would be used to purchase treasury stock) (in thousands)		986		657		-

	Weighted average number of shares of common stock used to compute diluted net income (loss) per share (in thousands)		22,954		22,906		21,950

	Basic net income (loss) per share	$	0.16	$	0.12	$	(0.37	)

	Diluted net income (loss) per share	$	0.16	$	0.12	$	(0.37	)

Note_17_Restructuring_Costs_an

Note 17 - Restructuring Costs and Other	12 Months Ended
	Dec. 31, 2014
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	NOTE 17:-	RESTRUCTURING COSTS AND OTHER

		a.	During the third quarter of 2012, the Company initiated a restructuring plan in order to improve operating efficiencies and reduce its operating expenses for fiscal year 2012 and subsequent periods. As part of this restructuring plan, the Company executed termination agreements with certain of its employees. During the third quarter of 2012, the Company recorded an expense in the amount of $1,315, consisting mainly of employee severance costs and the future expected under-utilization of existing development tool agreements with expiry dates in 2013 and 2014. All restructuring payments related to this restructuring plan were paid as of December 31, 2014.

		b.	During the second quarter of 2012, as part of the Company's plan to improve operating efficiencies and reduce its operating expenses for fiscal year 2012 and subsequent periods, it restructured its operations. As part of this restructuring plan, the Company executed termination agreements with certain of its employees. During the second quarter of 2012, the Company recorded an expense in the amount of $693, consisting mainly of employee severance costs. The Company anticipates that the remaining accrued restructuring cost balance of $39 will be paid out in cash throughout 2015.

Note_18_Segment_Information

Note 18 - Segment Information	12 Months Ended
Note 18 - Segment Information	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	NOTE 18:-	SEGMENT INFORMATION

	Description of segments:

	Until the second quarter of 2012, the Company operated under one reporting segment. During the third quarter of 2012, following a change in the manner management evaluates financial information, the Company determined that it operates under three reportable segments.

	The Company's segment information has been prepared in accordance with ASC 280, "Segment Reporting." Operating segments are defined as components of an enterprise engaging in business activities about which separate financial information is available that is evaluated regularly by the Company's chief operating decision-maker (“CODM”) in deciding how to allocate resources and assess performance. The Company's CODM is its Chief Executive Officer, who evaluates the Company's performance and allocates resources based on segment revenues and operating income.

	The Company's operating segments are as follows: Home, Office and Mobile. The classification of the Company’s business segments is based on a number of factors that management uses to evaluate, view and run its business operations, which include, but are not limited to, customer base, homogeneity of products and technology.

	A description of the types of products provided by each business segment is as follows:

	Home - Wireless chipset solutions for converged communication at home. Such solutions include integrated circuits targeted for cordless phones sold in retail or supplied by telecommunication service providers, home gateway devices supplied by telecommunication service providers which integrate the DECT/CAT-iq functionality and also address home automation applications, as well as fixed-mobile convergence solutions. In this segment, revenues from cordless telephony products exceeded 10% of the Company’s total consolidated revenues and amounted to 79%, 85% and 88% of the Company’s total revenues for 2014, 2013 and 2012, respectively.

	Office - Comprehensive solution for Voice-over-IP (VoIP) office products, including office solutions that offer businesses of all size low-cost VoIP terminals with converged voice and data applications. No revenues derived from products in the Office segment exceeded 10% of the Company’s total consolidated revenues for the years 2014,2013 and 2012.

	Mobile - Products for the mobile market that provides voice enhancement and far-end noise elimination targeted for mobile phone and mobile headsets. Insignificant revenues were derived from this segment for 2014, 2013 and 2012.

	Segment data:

	The Company derives the results of its business segments directly from its internal management reporting system and by using certain allocation methods. The accounting policies the Company uses to derive business segment results are substantially the same as those the Company uses for consolidation of its financial statements. the CODM measures the performance of each business segment based on several metrics, including earnings from operations. CODM uses these results, in part, to evaluate the performance of, and to assign resources to, each of the business segments. The Company does not allocate to its business segments certain operating expenses, which it manages separately at the corporate level. These unallocated costs include primarily restructuring charges, amortization of purchased intangible assets, equity-based compensation expenses, proxy contest related expenses incurred during the second quarter of 2013 and certain corporate governance costs.

	The Company does not allocate any assets to segments and, therefore, no amount of assets is reported to management and disclosed in the financial information for segments. Selected operating results information for each business segment was as follows for the year ended December 31, 2014, 2013 and 2012:

			Year ended December 31
			Revenues										Income (loss) from operations
			2014				2013			2012			2014			2013			2012
	Home		$	128,690			$	142,144		$	155,211		$	23,438		$	25,367		$	15,040
	Office		$	14,276			$	8,849		$	7,579		$	(2,805	)	$	(4,656	)	$	(5,156	)
	Mobile		$	70			$	70		$	-		$	(11,983	)	$	(11,040	)	$	(8,585	)
	Total		$	143,036			$	151,063		$	162,790		$	8,650		$	9,671		$	1,299

	The reconciliation of segment operating results information to the Company’s consolidated financial information was as follows:

			Year ended December 31,
			2014				2013			2012
	Income from operations		$	8,650			$	9,671		$	1,299
	Unallocated corporate, general and administrative expenses *			(2,161	)			(2,368	)		(2,600	)
	Restructuring expenses			-				-			(2,008	)
	Proxy contest related expenses			-				(1,403	)		-
	Equity-based compensation expenses			(5,359	)			(4,159	)		(4,983	)
	Intangible assets amortization expenses			(1,573	)			(1,672	)		(2,310	)
	Financial income, net			1,204				2,457			2,388
	Total consolidated income (loss) before taxes		$	761			$	2,526		$	(8,214	)

	*Includes mainly legal, accounting, board of directors and investors relation expenses.

	Major customers and geographic information

	The following is a summary of operations within geographic areas based on customer locations:

			Year ended December 31,
			2014				2013			2012
	Revenue distribution

	Hong-Kong		$	79,622			$	86,090		$	84,737
	Japan			31,261				34,377			51,033
	Europe			6,787				7,370			7,429
	United States			4,702				4,342			2,028
	China			6,568				6,999			6,270
	Taiwan			9,077				7,093			6,496
	Other			5,019				4,792			4,797

			$	143,036			$	151,063		$	162,790

For a summary of revenues from major customers, please see Note 1. Sales to these customers were primarily related to the Company's Home reportable segment.

The following is a summary of long-lived assets within geographic areas based on the assets' locations:

		December 31,
		2014				2013
Long-lived assets

Europe		$	188			$	158
Israel			2,264				2,260
United States			-				1
Other			391				418

		$	2,843			$	2,837

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Use of Estimates, Policy [Policy Text Block]

Basis of Accounting, Policy [Policy Text Block]

Accumulated other comprehensive loss related to foreign currency translation adjustments, net amounted to $218 and $193 as of December 31, 2014 and 2013, respectively.

Consolidation, Policy [Policy Text Block]

The consolidated financial statements include the accounts of the Company. Intercompany transactions and balances have been eliminated in consolidation.

Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]

Cash equivalents are short-term highly liquid investments, which are readily convertible to cash with original maturity of three months or less from the date of acquisition.

Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]

Restricted deposits include deposits which are used as security for derivative instruments and for one of the Company's lease agreements.

Deposit Contracts, Policy [Policy Text Block]

Bank deposits with original maturities of more than three months and less than one year are presented at cost, including accrued interest.

Marketable Securities, Available-for-sale Securities, Policy [Policy Text Block]

The Company classified all of its investments in marketable securities as available for sale.

Fair Value Measurement, Policy [Policy Text Block]

Level 1-

Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2-

Include other inputs that are directly or indirectly observable in the marketplace.

Level 3-

Unobservable inputs which are supported by little or no market activity.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

Inventory, Policy [Policy Text Block]

Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence.

Cost is determined as follows:

Work in progress and finished products- on the basis of raw materials and manufacturing costs on an average basis.

Property, Plant and Equipment, Policy [Policy Text Block]

Property and equipment, net:

Computers and equipment

20 - 33

Office furniture and equipment

15-Jun

Leasehold improvements

The shorter of term of the lease or the useful life of the asset

During the years ended December 31, 2014, 2013 and 2012, no impairment losses were identified for property and equipment.

Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]

Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test.

The Company performs an annual impairment test on December 31 of each fiscal year, or more frequently if impairment indicators are present.

The Company's reporting units are consistent with the reportable segments identified in Note 18.

For the fiscal year ended December 31, 2014, 2013 and 2012, the Company performed a quantitative assessment on its goodwill and no impairment losses were identified.

If such asset is considered to be impaired, the impairment to be recognized is measured as the difference between the carrying amount of the assets and the fair value of the impaired asset.

During 2014, 2013 and 2012, no impairment losses were identified.

Severance Pay [Policy Text Block]

Severance expenses for the years ended December 31, 2014, 2013 and 2012, were $1,568, $1,494 and $1,660, respectively.

Revenue Recognition, Policy [Policy Text Block]

The Company generates its revenues from sales of products. The Company sells its products through a direct sales force and through a network of distributors.

Standard Product Warranty, Policy [Policy Text Block]

Research and Development Expense, Policy [Policy Text Block]

Research and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.

Government Grants [Policy Text Block]

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

FASB ASC No. 718 requires cash flows resulting from tax deductions in excess of the compensation costs recognized for those equity-based awards to be classified as financing cash flows.

Earnings Per Share, Policy [Policy Text Block]

Income Tax, Policy [Policy Text Block]

Concentration Risk, Credit Risk, Policy [Policy Text Block]

The Company has no off-balance-sheet concentration of credit risk, except for certain derivative instruments as mentioned below.

Derivatives, Policy [Policy Text Block]

The fair value of the outstanding derivative instruments at December 31, 2014 and 2013 is summarized below:

Fair value of

derivative instruments

Derivative assets

As of December 31,

(liabilities)

Balance sheet location

2014

2013

Foreign exchange forward contracts and put and call options

Accrued expenses and other accounts payable

(618

)

Total

(618

)

The effect of derivative instruments in cash flow hedging transactions on income and other comprehensive income ("OCI") for the years ended December 31, 2014, 2013 and 2012 is summarized below:

Gains (losses) on derivatives

recognized in OCI

Year ended December 31,

2014

2013

2012

Foreign exchange forward contracts and put and call options

(1,180

)

372

635

Gains (losses) on derivatives reclassified

from OCI to income

Year ended December 31,

Location

2014

2013

2012

Foreign exchange forward contracts and put and call options

Operating expenses

(562

)

856

(325

)

As of December 31, 2014 and 2013, the Company had outstanding option contracts in the amount of $16,575 and $0, respectively.

Comprehensive Income, Policy [Policy Text Block]

The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for 2014:

Unrealized gains (losses) on available-for-sale marketable securities

Unrealized gains (losses) on Cash Flow Hedges

Unrealized gains (losses) on components of defined benefit plans

Unrealized gains (losses) on foreign currency translation

Total

Beginning balance

(391

)

(237

)

(193

)

(821

)

Other comprehensive income (loss) before reclassifications

157

(1,180

)

(209

)

(25

)

(1,257

)

Amounts reclassified from accumulated other comprehensive income (loss)

(61

)

562

512

Net current period other comprehensive income (loss)

(618

)

(198

)

(25

)

(745

)

Ending balance

(295

)

(618

)

(435

)

(218

)

(1,566

)

The following table provides details about reclassifications out of accumulated other comprehensive income (loss) for 2014:

Details about Accumulated

Amount

Affected Line Item in the

Other Comprehensive Income

Reclassified from

Statement of Income (Loss)

(Loss) Components

Accumulated Other

Comprehensive

Income (Loss)

(In millions)

Gains on available-for-sale marketable securities

(61

)

Financial income, net

Provision for income taxes

(61

)

Total, net of income taxes

Gains on cash flow hedges

441

Research and development

Sales and marketing

General and administrative

562

Total, before income taxes

Provision for income taxes

562

Total, net of income taxes

Income on components of defined benefit plans

Research and development

Sales and marketing

Total, before income taxes

Provision for income taxes

Total, net of income taxes

Total reclassifications for the period

512

Total, net of income taxes

Treasury Stock [Policy Text Block]

Cost Method Investments, Policy [Policy Text Block]

New Accounting Pronouncements, Policy [Policy Text Block]

Note_2_Significant_Accounting_1

Note 2 - Significant Accounting Policies (Tables)	12 Months Ended
Note 2 - Significant Accounting Policies (Tables)	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule of Useful Life of Property and Equipment [Table Text Block]		%

	Computers and equipment	20 - 33
	Office furniture and equipment	15-Jun

	Leasehold improvements	The shorter of term of the lease or the useful life of the asset
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]				Fair value of
				derivative instruments
	Derivative assets			As of December 31,
	(liabilities)	Balance sheet location		2014				2013

	Foreign exchange forward contracts and put and call options	Accrued expenses and other accounts payable		$	(618	)		$	-

		Total		$	(618	)		$	-
Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]		Gains (losses) on derivatives
		recognized in OCI
		Year ended December 31,
		2014				2013				2012

	Foreign exchange forward contracts and put and call options	$	(1,180	)		$	372			$	635
Derivative Instruments, Gain (Loss) [Table Text Block]				Gains (losses) on derivatives reclassified
				from OCI to income
				Year ended December 31,
		Location		2014				2013				2012

	Foreign exchange forward contracts and put and call options	Operating expenses		$	(562	)		$	856			$	(325	)
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]		Unrealized gains (losses) on available-for-sale marketable securities				Unrealized gains (losses) on Cash Flow Hedges				Unrealized gains (losses) on components of defined benefit plans				Unrealized gains (losses) on foreign currency translation			Total
	Beginning balance	$	(391	)		$	-			$	(237	)		$	(193	)	$	(821	)
	Other comprehensive income (loss) before reclassifications		157				(1,180	)			(209	)			(25	)		(1,257	)
	Amounts reclassified from accumulated other comprehensive income (loss)		(61	)			562				11				-			512
	Net current period other comprehensive income (loss)		96				(618	)			(198	)			(25	)		(745	)

	Ending balance	$	(295	)		$	(618	)		$	(435	)		$	(218	)	$	(1,566	)
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	Details about Accumulated	Amount			Affected Line Item in the
	Other Comprehensive Income	Reclassified from			Statement of Income (Loss)
	(Loss) Components	Accumulated Other
		Comprehensive
		Income (Loss)
		(In millions)
	Gains on available-for-sale marketable securities	$	(61	)	Financial income, net
			-		Provision for income taxes
			(61	)	Total, net of income taxes

	Gains on cash flow hedges
			441		Research and development
			43		Sales and marketing
			78		General and administrative
			562		Total, before income taxes
			-		Provision for income taxes
			562		Total, net of income taxes

	Income on components of defined benefit plans		6		Research and development
			5		Sales and marketing
			11		Total, before income taxes
			-		Provision for income taxes
			11		Total, net of income taxes

	Total reclassifications for the period		512		Total, net of income taxes

Note_3_Marketable_Securities_a1

Note 3 - Marketable Securities and Time Deposits (Tables)	12 Months Ended
Note 3 - Marketable Securities and Time Deposits (Tables)	Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]
Available-for-sale Securities [Table Text Block]		Amortized cost				Unrealized gains (losses), net						Fair value
		2014		2013		2014			2013			2014		2013

	Short term deposit	$	2,599	$	2,911	$	-		$	-		$	2,599	$	2,911
	U.S. GSE securities		21,085		3,093		(34	)		(11	)		21,051		3,082
	Corporate obligations		80,389		98,444		(262	)		(380	)		80,127		98,064

		$	104,072	$	104,448	$	(296	)	$	(391	)	$	103,777	$	104,057
Investments Classified by Contractual Maturity Date [Table Text Block]		Amortized		Unrealized gains (losses)					Fair
		cost		Gains		Losses			value

	Due in one year or less	$	8,910	$	4	$	(5	)	$	8,909
	Due after one year to five years		92,564		110		(405	)		92,269

		$	101,474	$	114	$	(410	)	$	101,178
		Amortized		Unrealized gains (losses)					Fair
		cost		Gains		Losses			value

	Due in one year or less	$	10,961	$	23	$	-		$	10,984
	Due after one year to six years		90,576		162		(576	)		90,162

		$	101,537	$	185	$	(576	)	$	101,146

Note_4_Other_Accounts_Receivab1

Note 4 - Other Accounts Receivable and Prepaid Expenses (Tables)	12 Months Ended
	Dec. 31, 2014
Other Accounts Receivable And Prepaid Expenses Disclosure [Abstract]
Schedule of Other Accounts Receivable [Table Text Block]		December 31,
		2014		2013
	Prepaid expenses	$	1,010	$	1,706
	Tax and governmental receivables		649		652

	Deposits		208		201
	Others		35		82

		$	1,902	$	2,641

Note_5_Inventories_Tables

Note 5 - Inventories (Tables)	12 Months Ended
Note 5 - Inventories (Tables)	Dec. 31, 2014
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]		December 31,
		2014		2013

	Work-in-progress	$	6,795	$	5,412
	Finished products		8,840		6,922

		$	15,635	$	12,334

Note_6_Property_and_Equipment_

Note 6 - Property and Equipment (Tables)	12 Months Ended
Note 6 - Property and Equipment (Tables)	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		December 31,
		2014		2013
	Cost:
	Computers and equipment	$	17,793	$	40,624
	Office furniture and equipment		1,446		1,590
	Leasehold improvements		4,559		4,651

			23,798		46,865
	Less - accumulated depreciation		20,955		44,028

	Depreciated cost	$	2,843	$	2,837

Note_7_Intangible_Asset_Net_Ta

Note 7 - Intangible Asset, Net (Tables)	12 Months Ended
Note 7 - Intangible Asset, Net (Tables)	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]		Useful life		December 31,
		(years)		2014		2013

	Cost:
	Current technology		4.2 - 5.3	$	77,080	$	77,080
	Customer relations		7.3		23,477		23,477
	Technology (completion of the development of in-process R&D)		6		7,702		7,702
	Non-competition agreement		3		519		519

					108,778		108,778
	Accumulated amortization:
	Current technology				48,263		48,263
	Customer relations				13,407		13,274
	Technology (completion of the development of in-process R&D)				2,567		1,284
	Non-competition agreement				519		360

					64,756		63,181
	Impairment: (Note 7b)
	Current technology				28,817		28,817
	Customer relations				10,070		10,070

					38,887		38,887

	Amortized cost			$	5,135	$	6,710
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Year ending December 31,

	2015	$	1,284
	2016		1,284
	2017		1,284
	2018		1,283

		$	5,135

Note_8_Fair_Value_Measurements1

Note 8 - Fair Value Measurements (Tables)	12 Months Ended
Note 8 - Fair Value Measurements (Tables)	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]		Balance as of			Fair value measurements
	Description	December 31,			Level 1		Level 2			Level 3
	Description	2014			Level 1		Level 2			Level 3

	Assets

	Cash equivalents
	Money market mutual funds	$	2,746		$	2,746		-			-

	Short-term marketable securities and time deposits
	U.S. GSE securities	$	1,499			-	$	1,499			-
	Corporate debt securities	$	7,410			-	$	7,410			-

	Long-term marketable securities
	U.S. GSE securities	$	19,552			-	$	19,552			-
	Corporate debt securities	$	72,717			-	$	72,717			-

	Derivative liabilities	$	(618	)		-	$	(618	)		-
		Balance as of			Fair value measurements
	Description	December 31,			Level 1		Level 2			Level 3
	Description	2013			Level 1		Level 2			Level 3

	Assets

	Cash equivalents
	Money market mutual funds	$	3,762		$	3,762

	Short-term marketable securities and time deposits
	U.S. GSE securities	$	251				$	251			-
	Corporate debt securities	$	10,733				$	10,733			-

	Long-term marketable securities
	U.S. GSE securities	$	2,831				$	2,831			-
	Corporate debt securities	$	87,331				$	87,331			-

Note_10_Accrued_Expenses_and_O1

Note 10 - Accrued Expenses and Other Accounts Payable (Tables)	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]		December 31,
		2014		2013

	Accrued expenses	$	3,279	$	3,324
	Derivative instruments		618		-
	Legal, accounting and investors relation accrual		543		779
	Royalties and commission		538		640
	Others		874		789

		$	5,852	$	5,532

Note_11_Accrued_Pension_Liabil1

Note 11 - Accrued Pension Liabilities (Tables)	12 Months Ended
Note 11 - Accrued Pension Liabilities (Tables)	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]		December 31,
		2014			2013

	Accumulated benefit obligation	$	1,194		$	1,227

	Change in benefit obligation

	Benefit obligation at beginning of year	$	1,239		$	1,334
	Service cost		5			5
	Interest cost		29			35
	Benefits paid from the plan		(152	)		(181	)
	Actuarial loss		218			1
	Exchange rates and others		(134	)		45

	Benefit obligation at end of year	$	1,205		$	1,239

	Change in plan assets

	Fair value of plan assets at beginning of year		258			364
	Actual return on plan assets		6			6
	Employer contributions to plan		-			-
	Benefits paid from the plan		(127	)		(123	)
	Exchange rates		(21	)		11

	Fair value of plan assets at end of year	$	116		$	258
Schedule of Assumptions Used [Table Text Block]		Year ended December 31,
		2014			2013			2012
	Weighted-average assumptions
	Discount rate		2.1	%		3.5	%		3.6	%
	Expected return on plan assets		2.86	%		2.88	%		2.88	%
	Rate of compensation increase		2.5	%		2.5	%		2.5	%
Schedule of Net Benefit Costs [Table Text Block]		December 31,
		2014			2013			2012
	Components of net periodic benefit cost

	Service cost	$	5		$	5		$	61
	Interest cost		29			35			47
	Expected return on plan assets		(6	)		(6	)		(12	)
	Amortization of net loss		11			11			2

	Net periodic benefit cost	$	39		$	45		$	98
Schedule of Amounts Recognized in Balance Sheet [Table Text Block]		December 31,
		2014			2013

	Net amounts recognized in the consolidated balance sheets as of December 31, 2014 and 2013 consist of:
	Current liabilities	$	-		$	-
	Noncurrent liabilities		1,089			981

	Net amounts recognized in the consolidated balance sheets	$	1,089		$	981

	Net amounts recognized in accumulated other comprehensive income as of December 31, 2014 and 2013 consist of:
	Net actuarial loss	$	(435	)	$	(237	)

	Net amounts recognized in accumulated other comprehensive loss	$	(435	)	$	(237	)
Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]		2015

	Net actuarial loss and other	$	22
Schedule of Expected Benefit Payments [Table Text Block]	Year ending December 31,

	2015	$	104
	2016	$	60
	2017	$	22
	2018	$	9
	2019	$	9
	2020-2024	$	99
Schedule of Allocation of Plan Assets [Table Text Block]		December 31,
		2014			2013

	Bonds		-			-
	Real estate		-			-
	Cash		-			-
	Shares		-			-
	Other		100	%		100	%

			100	%		100	%
Pension Plan Asset Allocations, Fair Value [Table Text Block]		Fair value measurements at December 31, 2014 using:

		Total fair			Quoted			Significant			Significant
		value at			prices in			other			unobservable
		December			active			observable			inputs
		31, 2014			markets			inputs			(Level 3)
					(Level 1)			(Level 2)

	Cash	$	-		$	-		$	-		$	-
	Equity securities		-			-			-			-
	Real estate		-			-			-			-
	Corporate bonds		-			-			-			-
	Others		116			-			116			-

	Total assets measured at fair value	$	116		$	-		$	116		$	-

Note_12_Financial_Income_Net_T

Note 12 - Financial Income, Net (Tables)	12 Months Ended
Note 12 - Financial Income, Net (Tables)	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Other Nonoperating Income (Expense) [Table Text Block]		Year ended December 31,
		2014		2013		2012

	Foreign exchange gains	$	27	$	-	$	120
	Interest income from marketable securities and deposits, net of amortization of premium on marketable securities		1,391		1,656		1,859
	Realized gains on marketable securities		73		1,013		708
	Other		-		13		1

	Financial income		1,491		2,682		2,688

	Realized losses on marketable securities		12		4		38
	Foreign exchange losses		113		86		88
	Interest expenses		24		29		35
	Other		138		106		139

	Financial expense		287		225		300

	Financial income, net	$	1,204	$	2,457	$	2,388

Note_13_Stockholders_Equity_Ta

Note 13 - Stockholders' Equity (Tables)	12 Months Ended
Note 13 - Stockholders' Equity (Tables)	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Schedule of Equity Based Awards Available For Future Issuances [Table Text Block]	ESPP		403,000
	Equity awards		594,000
	Undesignated preferred stock		5,000,000

			5,997,000
Schedule of Share-based Compensation, Activity [Table Text Block]		Year ended December 31,
		2014									2013							2012
		Amount of			Weighted			Aggregate			Amount of			Weighted		Aggregate		Amount of			Weighted		Aggregate
		options/			average			intrinsic			options/			average		intrinsic		options/			average		intrinsic
		SARs/RSUs			exercise price			value (4)			SARs/RSUs			exercise price		value (4)		SARs/RSUs			exercise price		value (4)
		in thousands									in thousands							in thousands

	Options outstanding at beginning of year		6,537		$	8.68		$	-			9,622		$	10.72	$	-		10,564		$	12.22	$	-
	Changes during the year:
	Options granted		232		$	9.15		$	-			524		$	6.42	$	-		310		$	5.67	$	-
	SARs granted (1)		-		$	-		$	-			-		$	-	$	-		1,100		$	6.16	$	-
	RSUs granted		337		$	-		$	-			552		$	-	$	-		-		$	-	$	-
	Exercised		(1,715	)	$	7.92		$	3,537			(2,105	)	$	6.49	$	3,795		(127	)	$	5.97	$	62

	Forfeited and cancelled		(747	)	$	20.11		$	-			(2,056	)	$	17.56	$	-		(2,225	)	$	15.14	$	-

	Options/SARs/RSUs outstanding at end of year (2)		4,644		$	6.52		$	21,409			6,537		$	8.68	$	16,673		9,622		$	10.72	$	98

	Options/SARs/RSUs exercisable at end of year (3)		3,106		$	7.73		$	10,941			4,623		$	10.3	$	7,230		7,223		$	12.07	$	28
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Range of	Outstanding			Remaining			Weighted			Exercisable			Remaining		Weighted
	exercise				contractual			average						contractual		average
	price				life (years)			exercise						life (years)		exercise
					-1			price								price
	$	thousands							$		thousands						$

	0 (RSUs)		660			-			-			-			-		-
	5.21-7.26		2,484			3.39			6.46			1,941			2.93		6.55
	7.49-10.23		1,345			3.71			8.44			1,010			2.54		8.33
	11.60-15.79		65			1.89			12.52			65			1.89		12.52
	21.07-25.06		90			1			23.03			90			1		23.03

			4,644			3.42			6.52			3,106			2.73		7.73
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]		Year ended December 31,
		2014			2013			2012

	Volatility		43.14	%		46.24	%		48.23	%
	Risk-free interest rate		1.85	%		1.39	%		2.2	%
	Dividend yield		0	%		0	%		0	%
	Pre-vest cancellation rate *)		4.17	%		3.48	%		3.5	%
	Post-vest cancellation rate **)		4.09	%		2.52	%		2.58	%
	Suboptimal exercise factor ***)		1.61			1.81			1.6
	Expected life (years)		3.27			4.66			4.19
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]	Non-vested	Units			Weighted average
					grant date fair
					value
		(In thousands)

	Non-vested at January 1, 2014		1,914			4.14

	Granted		569			6.12
	Vested		(918	)		3.89
	Forfeited		(27	)		4.26

	Non-vested at December 31, 2014		1,538			5.01

Note_14_Commitments_and_Contin1

Note 14 - Commitments and Contingencies (Tables)	12 Months Ended
Note 14 - Commitments and Contingencies (Tables)	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Year ended December 31,

	2015	$	2,977
	2016		2,584
	2017		1,687
	2018 and thereafter		1,360

		$	8,608

Note_15_Taxes_On_Income_Tables

Note 15 - Taxes On Income (Tables)	12 Months Ended
Note 15 - Taxes On Income (Tables)	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]		Year ended December 31,
		2014			2013			2012
	Domestic taxes

	Federal taxes:
	Current	$	-		$	(271	)	$	(465	)

	State taxes:
	Current		2			(9	)		1

	Foreign taxes:
	Current (1)		(1,672	)		507			304
	Deferred (2)		(1,170	)		(377	)		(12	)

			(2,842	)		130			292

	Income tax benefit	$	(2,840	)	$	(150	)	$	(172	)
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]		Year ended December 31,
		2014			2013			2012

	Domestic	$	(3,497	)	$	(3,525	)	$	(844	)
	Foreign		4,258			6,051			(7,370	)

		$	761		$	2,526		$	(8,214	)
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]		Year ended December 31,
		2014			2013			2012


	Income (loss) before taxes on income	$	761		$	2,526		$	(8,214	)

	Theoretical tax at U.S. statutory tax rate (35%)	$	266		$	884		$	(2,875	)
	State taxes, net of federal benefit		2			2			2
	Foreign income taxed at rates other than the U.S. rate (including deferred taxes that were not provided, valuation allowance and current adjustment and interest on uncertain tax position liability)		(5,974	)		(3,015	)		1,253
	Nondeductible equity-based compensation expenses		1,876			1,456			1,744
	Current adjustment and interest on uncertain tax position liability in U.S.		-			(283	)		(465	)
	Valuation allowance in U.S.		989			804			154
	Other		1			2			15

		$	(2,840	)	$	(150	)	$	(172	)
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]		December 31,
		2014			2013

	Deferred tax assets (short-term):

	Reserves and accruals	$	149		$	92
	Carryforward tax losses	$	626		$	-

	Total deferred tax assets (short-term)		775			92
	Valuation allowance		-			-

	Total		775			92

	Deferred tax assets (long-term):

	Reserves and accruals		1,669			1,074
	Equity-based compensation		2,761			2,526
	Intangible assets		1,198			1,453
	Carryforward tax losses		27,621			31,817
	Other		15			16

	Total deferred tax assets (long-term)		33,264			36,886
	Valuation allowance		(33,115	)		(36,886	)

	Total		149			-

	Total deferred tax assets	$	924		$	92

	Deferred tax liabilities, net (Long term):
	Acquired intangible assets		1,360			1,670
	Acquired carryforward tax losses		(515	)		(487	)

	Total deferred tax liabilities, net	$	845		$	1,183
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]		2014			2013

	Gross unrecognized tax benefits at January 1	$	1,892		$	1,815
	Decrease in tax positions for previous years		(104	)		-
	Increases in tax positions for previous years		115			59
	Increases in tax positions for current year		71			109
	Change in interest and linkage related to tax positions		(85	)		193
	Lapse in statute of limitations or finalization of tax assessment		(858	)		(284	)

	Gross unrecognized tax benefits at December 31	$	1,031		$	1,892

Note_16_Basic_and_Diluted_Loss1

Note 16 - Basic and Diluted Loss Per Share (Tables)	12 Months Ended
Note 16 - Basic and Diluted Loss Per Share (Tables)	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]		Year ended December 31,
		2014		2013		2012
	Numerator:

	Net income (loss)	$	3,602	$	2,676	$	(8,042	)

	Denominator:

	Weighted average number of shares of common stock outstanding during the year used to compute basic net income (loss) per share (in thousands)		21,968		22,249		21,950

	Incremental shares attributable to exercise of outstanding options, SARs and RSUs (assuming proceeds would be used to purchase treasury stock) (in thousands)		986		657		-

	Weighted average number of shares of common stock used to compute diluted net income (loss) per share (in thousands)		22,954		22,906		21,950

	Basic net income (loss) per share	$	0.16	$	0.12	$	(0.37	)

	Diluted net income (loss) per share	$	0.16	$	0.12	$	(0.37	)

Note_18_Segment_Information_Ta

Note 18 - Segment Information (Tables)	12 Months Ended
Note 18 - Segment Information (Tables)	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]		Year ended December 31
		Revenues									Income (loss) from operations
		2014			2013			2012			2014			2013			2012
	Home	$	128,690		$	142,144		$	155,211		$	23,438		$	25,367		$	15,040
	Office	$	14,276		$	8,849		$	7,579		$	(2,805	)	$	(4,656	)	$	(5,156	)
	Mobile	$	70		$	70		$	-		$	(11,983	)	$	(11,040	)	$	(8,585	)
	Total	$	143,036		$	151,063		$	162,790		$	8,650		$	9,671		$	1,299
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]		Year ended December 31,
		2014			2013			2012
	Income from operations	$	8,650		$	9,671		$	1,299
	Unallocated corporate, general and administrative expenses *		(2,161	)		(2,368	)		(2,600	)
	Restructuring expenses		-			-			(2,008	)
	Proxy contest related expenses		-			(1,403	)		-
	Equity-based compensation expenses		(5,359	)		(4,159	)		(4,983	)
	Intangible assets amortization expenses		(1,573	)		(1,672	)		(2,310	)
	Financial income, net		1,204			2,457			2,388
	Total consolidated income (loss) before taxes	$	761		$	2,526		$	(8,214	)
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]		Year ended December 31,
		2014			2013			2012
	Revenue distribution

	Hong-Kong	$	79,622		$	86,090		$	84,737
	Japan		31,261			34,377			51,033
	Europe		6,787			7,370			7,429
	United States		4,702			4,342			2,028
	China		6,568			6,999			6,270
	Taiwan		9,077			7,093			6,496
	Other		5,019			4,792			4,797

		$	143,036		$	151,063		$	162,790
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]		December 31,
		2014			2013
	Long-lived assets

	Europe	$	188		$	158
	Israel		2,264			2,260
	United States		-			1
	Other		391			418

		$	2,843		$	2,837

Note_1_General_Details

Note 1 - General (Details) (Sales Revenue, Net [Member], Customer Concentration Risk [Member])	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
VTech Holdings Ltd. [Member]
Note 1 - General (Details) [Line Items]
Concentration Risk, Percentage	35.00%	36.00%	35.00%
Tomen Electronics Corporation [Member]
Note 1 - General (Details) [Line Items]
Concentration Risk, Percentage	20.00%	19.00%	21.00%
Panasonic Communications Corporation [Member]
Note 1 - General (Details) [Line Items]
Concentration Risk, Percentage	15.00%	14.00%	15.00%
Uniden America Corporation [Member]
Note 1 - General (Details) [Line Items]
Concentration Risk, Percentage	2.00%	4.00%	11.00%

Note_2_Significant_Accounting_2

Note 2 - Significant Accounting Policies (Details) (USD $)	3 Months Ended		12 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2012	Jun. 30, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 2 - Significant Accounting Policies (Details) [Line Items]
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax			$218	$193
Inventory, Net			15,635	12,334
Inventory Valuation Reserves			505	591
Impairment of Long-Lived Assets Held-for-use			0	0	0
Capitalized Computer Software, Additions			128	34	22
Goodwill, Impairment Loss			0	0	0
Severance Costs	1,315	693	1,568	1,494	1,660
Product Warranty Term			1 year
Share-based Compensation Arrangement byShare-based Payment Award, Number of Expired Equity Incentive Plans			2
Share-based Compensation Arrangement by Share-based Payment Award, Number of Equity Incentive Plans			3
Share-based Compensation, Employee Stock Purchase Plan, Number of Plans				1
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)			1,811,687	2,730,867	7,584,336
Available-for-sale Securities, Amortized Cost Basis			104,072	104,448
Available-for-sale Securities			103,777	104,057
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax			410	576
Allowance for Doubtful Accounts Receivable			0	0
Debt Securities [Member]
Note 2 - Significant Accounting Policies (Details) [Line Items]
Available-for-sale Securities, Amortized Cost Basis			101,474	101,537
Available-for-sale Securities			101,178	101,146
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax			296
Computer Software, Intangible Asset [Member]
Note 2 - Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life			3 years
Foreign Exchange Option [Member]
Note 2 - Significant Accounting Policies (Details) [Line Items]
Price Risk Cash Flow Hedge Asset, at Fair Value			16,575	0
Royalty Bearing Grants [Member]
Note 2 - Significant Accounting Policies (Details) [Line Items]
Financial Grants in Support of Research and Development			3,002	2,116
Non Royalty Bearing Grants [Member]
Note 2 - Significant Accounting Policies (Details) [Line Items]
Financial Grants in Support of Research and Development					$386
Minimum [Member]
Note 2 - Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life			3 years
Derivative Instrument Hedging Period			1 month
Maximum [Member]
Note 2 - Significant Accounting Policies (Details) [Line Items]
Finite-Lived Intangible Asset, Useful Life			7 years 109 days
Derivative Instrument Hedging Period			12 months

Note_2_Significant_Accounting_3

Note 2 - Significant Accounting Policies (Details) - Property and Equipment Depreciation Rates	12 Months Ended
	Dec. 31, 2014
Computer Equipment [Member] \| Minimum [Member]
Note 2 - Significant Accounting Policies (Details) - Property and Equipment Depreciation Rates [Line Items]
Property and equipment, annual depreciation rates	20.00%
Computer Equipment [Member] \| Maximum [Member]
Note 2 - Significant Accounting Policies (Details) - Property and Equipment Depreciation Rates [Line Items]
Property and equipment, annual depreciation rates	33.00%
Office Furniture and Equipment [Member] \| Minimum [Member]
Note 2 - Significant Accounting Policies (Details) - Property and Equipment Depreciation Rates [Line Items]
Property and equipment, annual depreciation rates	6.00%
Office Furniture and Equipment [Member] \| Maximum [Member]
Note 2 - Significant Accounting Policies (Details) - Property and Equipment Depreciation Rates [Line Items]
Property and equipment, annual depreciation rates	15.00%
Leasehold Improvements [Member]
Note 2 - Significant Accounting Policies (Details) - Property and Equipment Depreciation Rates [Line Items]
Leasehold improvements	The shorter of term of the lease or the useful life of the asset

Note_2_Significant_Accounting_4

Note 2 - Significant Accounting Policies (Details) - Fair Value of the Outstanding Derivative Instruments (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014
Derivatives, Fair Value [Line Items]
Fair value of derivative instruments	($618)
Foreign Exchange Forward Contracts and Put Options [Member] \| Prepaid Expenses and Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Fair value of derivative instruments	($618)

Note_2_Significant_Accounting_5

Note 2 - Significant Accounting Policies (Details) - Effect of Derivative Instruments in Cash Flow Hedging Transactions on Income and Other Comprehensive Income (Gains (Losses) on Derivatives Recognized in OCI (Foreign Exchange Contract [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Foreign Exchange Contract [Member]
Note 2 - Significant Accounting Policies (Details) - Effect of Derivative Instruments in Cash Flow Hedging Transactions on Income and Other Comprehensive Income (Gains (Losses) on Derivatives Recognized in OCI [Line Items]
Foreign exchange forward contracts and put and call options	($1,180)	$372	$635

Note_2_Significant_Accounting_6

Note 2 - Significant Accounting Policies (Details) - Gains (Losses) on Derivatives Reclassified from OCI to Income (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Gains (Losses) on Derivatives Reclassified from OCI to Income [Abstract]
Foreign exchange forward contracts and put and call options	($562)	$856	($325)

Note_2_Significant_Accounting_7

Note 2 - Significant Accounting Policies (Details) - Changes in Accumulated Other Comprehensive Income (Loss) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	($821)
Other comprehensive income (loss) before reclassifications	-1,257
Amounts reclassified from accumulated other comprehensive income (loss)	512
Net current period other comprehensive income (loss)	-745	-1,809	2,744
Ending balance	-1,566	-821
Accumulated Net Unrealized Investment Gain (Loss) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	-391
Other comprehensive income (loss) before reclassifications	157
Amounts reclassified from accumulated other comprehensive income (loss)	-61
Net current period other comprehensive income (loss)	96
Ending balance	-295
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications	-1,180
Amounts reclassified from accumulated other comprehensive income (loss)	562
Net current period other comprehensive income (loss)	-618
Ending balance	-618
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	-237
Other comprehensive income (loss) before reclassifications	-209
Amounts reclassified from accumulated other comprehensive income (loss)	11
Net current period other comprehensive income (loss)	-198
Ending balance	-435
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balance	-193
Other comprehensive income (loss) before reclassifications	-25
Net current period other comprehensive income (loss)	-25
Ending balance	($218)

Note_2_Significant_Accounting_8

Note 2 - Significant Accounting Policies (Details) - Reclassifications Out of Accumulated Other Comprehensive Income (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains on available-for-sale marketable securities	$1,204		$2,457		$2,388
Net income (loss)	3,602		2,676		-8,042
Research and development	33,468	[1]	35,000	[1]	42,539	[1]
Sales and marketing	11,905	[2]	11,273	[2]	14,237	[2]
	10,541	[3]	11,812	[3]	10,638	[3]
Total, before income taxes	761		2,526		-8,214
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Accumulated Net Unrealized Investment Gain (Loss) [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains on available-for-sale marketable securities	-61,000
Net income (loss)	-61,000
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income (loss)	562,000
Research and development	441,000
Sales and marketing	43,000
	78,000
Total, before income taxes	562,000
Reclassification out of Accumulated Other Comprehensive Income [Member] \| Accumulated Defined Benefit Plans Adjustment [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income (loss)	11,000
Research and development	6,000
Sales and marketing	5,000
Total, before income taxes	11,000
Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Net income (loss)	$512,000

[1]	Includes equity-based compensation expense in the amount of $2,381, $1,873 and $2,425 for the years ended December 31, 2014, 2013 and 2012, respectively.
[2]	Includes equity-based compensation expense in the amount of $621, $478 and $778 for the years ended December 31, 2014, 2013 and 2012, respectively.
[3]	Includes equity-based compensation expense in the amount of $2,057, $1,555 and $1,450 for the years ended December 31, 2014, 2013 and 2012, respectively.

Note_3_Marketable_Securities_a2

Note 3 - Marketable Securities and Time Deposits (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Investments, Debt and Equity Securities [Abstract]
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$68,945	$46,943
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax	410	576
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	113	145
Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss	297	431
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities	23,250	18,325	25,911
Proceeds from Sale of Available-for-sale Securities	46,491	42,949	39,063
Available-for-sale Securities, Gross Realized Gains	73	1,013	708
Available-for-sale Securities, Gross Realized Losses	$12	$4	$38

Note_3_Marketable_Securities_a3

Note 3 - Marketable Securities and Time Deposits (Details) - Marketable Securities and Time Deposits (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Schedule of Available-for-sale Securities [Line Items]
Marketable securities and time deposits, amortized cost	$104,072	$104,448
Marketable securities and time deposits, unrealized gains (losses), net	-296	-391
Marketable securities and time deposits, estimated fair value	103,777	104,057
Short-term Deposits [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable securities and time deposits, amortized cost	2,599	2,911
Marketable securities and time deposits, estimated fair value	2,599	2,911
US Government-sponsored Enterprises Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable securities and time deposits, amortized cost	21,085	3,093
Marketable securities and time deposits, unrealized gains (losses), net	-34	-11
Marketable securities and time deposits, estimated fair value	21,051	3,082
Corporate Debt Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Marketable securities and time deposits, amortized cost	80,389	98,444
Marketable securities and time deposits, unrealized gains (losses), net	-262	-380
Marketable securities and time deposits, estimated fair value	$80,127	$98,064

Note_3_Marketable_Securities_a4

Note 3 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Note 3 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost	$104,072	$104,448
Marketable debt securities, estimated fair value	103,777	104,057
Debt Securities [Member] \| Due in One Year or Less [Member]
Note 3 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost	8,910	10,961
Marketable debt securities, unrealized gains	4	23
Marketable debt securities, unrealized losses	-5
Marketable debt securities, estimated fair value	8,909	10,984
Debt Securities [Member] \| Due After One Year to Five Years [Member]
Note 3 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost	92,564
Marketable debt securities, unrealized gains	110
Marketable debt securities, unrealized losses	-405
Marketable debt securities, estimated fair value	92,269
Debt Securities [Member] \| Due After One Year to Six Years [Member]
Note 3 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost		90,576
Marketable debt securities, unrealized gains		162
Marketable debt securities, unrealized losses		-576
Marketable debt securities, estimated fair value		90,162
Debt Securities [Member]
Note 3 - Marketable Securities and Time Deposits (Details) - Marketable Debt Securities by Contractual Maturities [Line Items]
Marketable debt securities, amortized cost	101,474	101,537
Marketable debt securities, unrealized gains	114	185
Marketable debt securities, unrealized losses	-410	-576
Marketable debt securities, estimated fair value	$101,178	$101,146

Note_4_Other_Accounts_Receivab2

Note 4 - Other Accounts Receivable and Prepaid Expenses (Details) - Other Accounts Receivable and Prepaid Expenses (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Other Accounts Receivable and Prepaid Expenses [Abstract]
Prepaid expenses	$1,010	$1,706
Tax and governmental receivables	649	652
Deposits	208	201
Others	35	82
	$1,902	$2,641

Note_5_Inventories_Details

Note 5 - Inventories (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Inventory Disclosure [Abstract]
Inventory Write-down	$6	$261	$29

Note_5_Inventories_Details_Com

Note 5 - Inventories (Details) - Components of Inventories (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Components of Inventories [Abstract]
Work-in-progress	$6,795	$5,412
Finished products	8,840	6,922
	$15,635	$12,334

Note_6_Property_and_Equipment_1

Note 6 - Property and Equipment (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Disposals	$24,247
Depreciation, Depletion and Amortization, Nonproduction	$1,290	$1,994	$3,168

Note_6_Property_and_Equipment_2

Note 6 - Property and Equipment (Details) - Property and Equipment (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Cost:
Property and equipment	$23,798	$46,865
Less - accumulated depreciation	20,955	44,028
Depreciated cost	2,843	2,837
Computer Equipment [Member]
Cost:
Property and equipment	17,793	40,624
Office Furniture and Equipment [Member]
Cost:
Property and equipment	1,446	1,590
Leasehold Improvements [Member]
Cost:
Property and equipment	$4,559	$4,651

Note_7_Intangible_Asset_Net_De

Note 7 - Intangible Asset, Net (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Disclosure Text Block [Abstract]
Amortization of Intangible Assets	$1,573	$1,672	$2,310

Note_7_Intangible_Asset_Net_De1

Note 7 - Intangible Asset, Net (Details) - Intangible Assets (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Cost:
FiniteLivedIntangibleAssets	$108,778	$108,778
Accumulated amortization:
FiniteLivedIntangibleAssets	64,756	63,181
Impairment: (Note 7b)
FiniteLivedIntangibleAssets	38,887	38,887
Amortized cost	5,135	6,710
Technology-Based Intangible Assets [Member] \| Minimum [Member]
Cost:
Intangible assets, useful life	4 years 73 days
Technology-Based Intangible Assets [Member] \| Maximum [Member]
Cost:
Intangible assets, useful life	5 years 109 days
Technology-Based Intangible Assets [Member]
Cost:
FiniteLivedIntangibleAssets	77,080	77,080
Accumulated amortization:
FiniteLivedIntangibleAssets	48,263	48,263
Impairment: (Note 7b)
FiniteLivedIntangibleAssets	28,817	28,817
Customer Relationships [Member]
Cost:
Intangible assets, useful life	7 years 109 days
FiniteLivedIntangibleAssets	23,477	23,477
Accumulated amortization:
FiniteLivedIntangibleAssets	13,407	13,274
In Process Research and Development [Member]
Cost:
Intangible assets, useful life	6 years
FiniteLivedIntangibleAssets	7,702	7,702
Accumulated amortization:
FiniteLivedIntangibleAssets	2,567	1,284
Noncompete Agreements [Member]
Cost:
Intangible assets, useful life	3 years
FiniteLivedIntangibleAssets	519	519
Accumulated amortization:
FiniteLivedIntangibleAssets	519	360
Impairment: (Note 7b)
FiniteLivedIntangibleAssets	$10,070	$10,070
Minimum [Member]
Cost:
Intangible assets, useful life	3 years
Maximum [Member]
Cost:
Intangible assets, useful life	7 years 109 days

Note_7_Intangible_Asset_Net_De2

Note 7 - Intangible Asset, Net (Details) - Estimated Amortization Expenses (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Estimated Amortization Expenses [Abstract]
2015	$1,284
2016	1,284
2017	1,284
2018	1,283
	$5,135	$6,710

Note_8_Fair_Value_Measurements2

Note 8 - Fair Value Measurements (Details) - Fair Value Measurements of Assets and Liabilities on Recurring Basis (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Derivative Financial Instruments, Liabilities [Member] \| Fair Value, Inputs, Level 2 [Member]
Long-term marketable securities
Derivative liabilities	($618)
Derivative Financial Instruments, Liabilities [Member]
Long-term marketable securities
Derivative liabilities	-618
Fair Value, Inputs, Level 1 [Member] \| Money Market Funds [Member] \| Fair Value, Measurements, Recurring [Member]
Long-term marketable securities
Cash equivalents	2,746
Fair Value, Inputs, Level 1 [Member] \| Money Market Funds [Member]
Long-term marketable securities
Cash equivalents		3,762
Fair Value, Inputs, Level 2 [Member] \| US Government-sponsored Enterprises Debt Securities [Member]
Short-term marketable securities and time deposits
Short-term marketable securities and time deposits	1,499	251
Long-term marketable securities
Long-term marketable securities	19,552	2,831
Fair Value, Inputs, Level 2 [Member] \| Corporate Debt Securities [Member]
Short-term marketable securities and time deposits
Short-term marketable securities and time deposits	7,410	10,733
Long-term marketable securities
Long-term marketable securities	72,717	87,331
Money Market Funds [Member] \| Fair Value, Measurements, Recurring [Member]
Long-term marketable securities
Cash equivalents	2,746
Money Market Funds [Member]
Long-term marketable securities
Cash equivalents		3,762
US Government-sponsored Enterprises Debt Securities [Member]
Short-term marketable securities and time deposits
Short-term marketable securities and time deposits	1,499	251
Long-term marketable securities
Long-term marketable securities	19,552	2,831
Corporate Debt Securities [Member]
Short-term marketable securities and time deposits
Short-term marketable securities and time deposits	7,410	10,733
Long-term marketable securities
Long-term marketable securities	$72,717	$87,331

Note_9_Investment_in_Other_Com1

Note 9 - Investment in Other Company (Details) (USD $)	12 Months Ended	0 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Oct. 24, 2013
Note 9 - Investment in Other Company (Details) [Line Items]
Payments to Acquire Investments	$2,200
Asian Private Company [Member]
Note 9 - Investment in Other Company (Details) [Line Items]
Payments to Acquire Investments		$2,200
Cost Method Investment, Ownership Percentage		14.00%

Note_10_Accrued_Expenses_and_O2

Note 10 - Accrued Expenses and Other Accounts Payable (Details) - Accrued Expenses and Other Accounts Payable (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Accrued Expenses and Other Accounts Payable [Abstract]
Accrued expenses	$3,279	$3,324
Derivative instruments	618
Legal, accounting and investors relation accrual	543	779
Royalties and commission	538	640
Others	874	789
	$5,852	$5,532

Note_11_Accrued_Pension_Liabil2

Note 11 - Accrued Pension Liabilities (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Compensation and Retirement Disclosure [Abstract]
Defined Benefit Plan, Corridor Percentage	10.00%
Defined Benefit Plan Actuarial Net Gains Losses Recognized	$209	$11	$160

Note_11_Accrued_Pension_Liabil3

Note 11 - Accrued Pension Liabilities (Details) - Changes in the Pension Plans' Benefit Obligation and Fair Value of Assets (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Changes in the Pension Plans' Benefit Obligation and Fair Value of Assets [Abstract]
Accumulated benefit obligation	$1,194	$1,227
Change in benefit obligation
Benefit obligation at beginning of year	1,239	1,334
Service cost	5	5	61
Interest cost	29	35	47
Benefits paid from the plan	-152	-181
Actuarial loss	218	1
Exchange rates and others	-134	45
Benefit obligation at end of year	1,205	1,239	1,334
Change in plan assets
Fair value of plan assets at beginning of year	258	364
Actual return on plan assets	6	6
Benefits paid from the plan	-127	-123
Exchange rates	-21	11
Fair value of plan assets at end of year	$116	$258	$364

Note_11_Accrued_Pension_Liabil4

Note 11 - Accrued Pension Liabilities (Details) - Assumptions Used in the Measurement of the Pension Expense and Benefit Obligations	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Weighted-average assumptions
Discount rate	2.10%	3.50%	3.60%
Expected return on plan assets	2.86%	2.88%	2.88%
Rate of compensation increase	2.50%	2.50%	2.50%

Note_11_Accrued_Pension_Liabil5

Note 11 - Accrued Pension Liabilities (Details) - Components of Net Periodic Benefit Costs (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Components of net periodic benefit cost
Service cost	$5	$5	$61
Interest cost	29	35	47
Expected return on plan assets	-6	-6	-12
Amortization of net loss	11	11	2
Net periodic benefit cost	$39	$45	$98

Note_11_Accrued_Pension_Liabil6

Note 11 - Accrued Pension Liabilities (Details) - Net Amounts Recognized in Consolidated Balance Sheets and Accumulated Other Comprehensive Income (Loss) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Net Amounts Recognized in Consolidated Balance Sheets and Accumulated Other Comprehensive Income (Loss) [Abstract]
Noncurrent liabilities	$1,089	$981
Net amounts recognized in the consolidated balance sheets	1,089	981
Net actuarial loss	-435	-237
Net amounts recognized in accumulated other comprehensive loss	($435)	($237)

Note_11_Accrued_Pension_Liabil7

Note 11 - Accrued Pension Liabilities (Details) - Estimated Amount That will Amortized from Accumulated Other Comprehensive Income (Loss) into Net Periodic Benefit Cost (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Estimated Amount That will Amortized from Accumulated Other Comprehensive Income (Loss) into Net Periodic Benefit Cost [Abstract]
Net actuarial loss and other	$22

Note_11_Accrued_Pension_Liabil8

Note 11 - Accrued Pension Liabilities (Details) - Benefit Payments Expected to Be Paid (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014
Benefit Payments Expected to Be Paid [Abstract]
2015	$104
2016	60
2017	22
2018	9
2019	9
2020-2024	$99

Note_11_Accrued_Pension_Liabil9

Note 11 - Accrued Pension Liabilities (Details) - Plan Asset Allocations	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note 11 - Accrued Pension Liabilities (Details) - Plan Asset Allocations [Line Items]
Plan asset allocations	100.00%	100.00%
Other Assets [Member]
Note 11 - Accrued Pension Liabilities (Details) - Plan Asset Allocations [Line Items]
Plan asset allocations	100.00%	100.00%

Recovered_Sheet1

Note 11 - Accrued Pension Liabilities (Details) - Fair Value of Pension Plan Assets (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 11 - Accrued Pension Liabilities (Details) - Fair Value of Pension Plan Assets [Line Items]
Pension plan assets	$116	$258	$364
Other Assets [Member] \| Fair Value, Inputs, Level 2 [Member]
Note 11 - Accrued Pension Liabilities (Details) - Fair Value of Pension Plan Assets [Line Items]
Pension plan assets	116
Other Assets [Member]
Note 11 - Accrued Pension Liabilities (Details) - Fair Value of Pension Plan Assets [Line Items]
Pension plan assets	116
Fair Value, Inputs, Level 2 [Member]
Note 11 - Accrued Pension Liabilities (Details) - Fair Value of Pension Plan Assets [Line Items]
Pension plan assets	$116

Note_12_Financial_Income_Net_D

Note 12 - Financial Income, Net (Details) - Components of Financial Income, Net (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Components of Financial Income, Net [Abstract]
Foreign exchange gains	$27		$120
Interest income from marketable securities and deposits, net of amortization of premium on marketable securities	1,391	1,656	1,859
Realized gains on marketable securities	73	1,013	708
Other		13	1
Financial income	1,491	2,682	2,688
Realized losses on marketable securities	12	4	38
Foreign exchange losses	113	86	88
Interest expenses	24	29	35
Other	138	106	139
Financial expense	287	225	300
Financial income, net	$1,204	$2,457	$2,388

Note_13_Stockholders_Equity_De

Note 13 - Stockholders' Equity (Details) (USD $)	12 Months Ended						1 Months Ended				168 Months Ended
Note 13 - Stockholders' Equity (Details) (USD $)	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012		Jan. 31, 2012	Jan. 31, 2011	Jan. 31, 2010	Jan. 31, 2009	Dec. 31, 2014	Nov. 30, 2013
Note 13 - Stockholders' Equity (Details) [Line Items]
Preferred Stock, Shares Authorized	5,000,000										5,000,000
Common Stock, Shares Authorized	50,000,000		50,000,000								50,000,000
Retained Earnings (Accumulated Deficit) (in Dollars)	($85,352,000)		($83,535,000)								-85,352,000
Stock Repurchase Program, Number of Additional Shares Authorized to Be Repurchased												2,700,000
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased	1,203,601										1,203,601	308,000
Treasury Stock, Shares, Acquired	1,414,000		390,000		1,283,000
Treasury Stock Acquired, Average Cost Per Share (in Dollars per share)	$8.83		$8.95		$6.28
Treasury Stock, Value, Acquired, Cost Method (in Dollars)	12,484,000		3,490,000		8,060,000
Stock Issued During Period, Shares, Employee Stock Ownership Plan	908,000		1,066,000		455,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	5,997,000										5,997,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	232,000		524,000		310,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	4,644,000										4,644,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans	403,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	3 years 98 days		4 years 240 days		4 years 69 days
Allocated Share-based Compensation Expense (in Dollars)	5,359,000		4,159,000		4,983,000
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense (in Dollars)	0		0		0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	3,376,000										3,376,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)	3,168,000										3,168,000
Common Stock [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Treasury Stock, Shares, Acquired	-1,414,000		-390,000		-1,283,000
Treasury Stock, Value, Acquired, Cost Method (in Dollars)	$1,000		$1,000		$1,000
Share Price (in Dollars per share)	$10.87		$9.71		$5.76						10.87
Restricted Stock Units (RSUs) [Member] \| First Anniversary [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	25.00%
Restricted Stock Units (RSUs) [Member] \| Each Quarter After First Anniversary [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	6.25%
Restricted Stock Units (RSUs) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	337,000		552,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)			$7.94
Share-based Compensation Arrangement by Share-based Payment Award, Weighted Average Pre Vest Cancel Rate			3.79%
First Option [Member] \| 1993 Director Stock Option Plan [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	30,000
Committee Option [Member] \| 1993 Director Stock Option Plan [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	15,000
Stock Appreciation Rights (SARs) [Member] \| In the Money [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	2,451,499										2,451,499
Stock Appreciation Rights (SARs) [Member] \| Maximum [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available For Grant as Percentage of Company S Outstanding Common Stock							50.00%	66.67%	75.00%	50.00%
Stock Appreciation Rights (SARs) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		[1]		[1]	1,100,000	[1]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	2,468,499										2,468,499
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$3.47		$4.90		$2.39
Subsequent Option [Member] \| 1993 Director Stock Option Plan [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	15,000
Minimum [Member] \| 1993 Employee Stock Purchase Plan (ESPP) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	6 months
Minimum [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options Grants in Period Exercise Price, Based on Percentage of Fair Market Value of Common Stock	100.00%
Maximum [Member] \| 1993 Employee Stock Purchase Plan (ESPP) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	29 months 1 day 19 hours 12 minutes		24 months
Maximum [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares to Be Issued Upon Exercise of Outstanding Awards	3,670,000										3,670,000
Share-based Compensation Arrangement by Share-based Payment Award, Options and Stock Appreciation Rights, Exercisable, Number	2,279,000										2,279,000
Non Employee Directors [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	8,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	4,000
1993 Director Stock Option Plan [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	1,980,875										1,980,875
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	2,464,933
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	540,000										540,000
1998 Non-Officer Employee Stock Option Plan [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	48 months
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	5,062,881										5,062,881
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	118,535										118,535
2001 Stock Incentive Plan [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options Grants in Period Exercise Price, Based on Percentage of Fair Market Value of Common Stock	100.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	48 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross											2,194,847
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	10,000										10,000
2003 Israeli Share Incentive Plan [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	48 months
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			10,700,543
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number			1,412,613
2012 Equity Incentive Plan [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	48 months
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	1,450,000										1,450,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	475,435										475,435
1993 Employee Stock Purchase Plan (ESPP) [Member]
Note 13 - Stockholders' Equity (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options Grants in Period Exercise Price, Based on Percentage of Fair Market Value of Common Stock	85.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	403,000										403,000
Employee Stock Purchase Plan, ESPP Shares Reserved For Future Purchase	3,800,000										3,800,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans	374,000		310,000		446,000
Employee Stock Ownership Plan (ESOP), Weighted Average Purchase Price of Shares Purchased (in Dollars per share)	$5.55		$4.44		$4.42
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum	36.37%		37.17%		35.79%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum	44.19%				42.02%

[1]	SAR grants made prior to January 1, 2009 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SAR unitssubject to the grant. SAR grants made on or after January 1, 2009 and before January 1, 2010 are convertible for a maximum number of shares of the Company'scommon stock equal to 75% of the SAR units subject to the grant. SAR grants made on or after January 1, 2010 are convertible for a maximum number of shares of the Company's common stock equal to 66.67% of the SAR units subject to the grant. SAR grants made on or after January 1, 2012 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SAR units subject to the grant.

Note_13_Stockholders_Equity_De1

Note 13 - Stockholders' Equity (Details) - Number of Shares Available for Future Issuance	Dec. 31, 2014
Note 13 - Stockholders' Equity (Details) - Number of Shares Available for Future Issuance [Line Items]
Shares available for future issuance	5,997,000
Equity Awards [Member]
Note 13 - Stockholders' Equity (Details) - Number of Shares Available for Future Issuance [Line Items]
Shares available for future issuance	594,000
Preferred Stock [Member]
Note 13 - Stockholders' Equity (Details) - Number of Shares Available for Future Issuance [Line Items]
Shares available for future issuance	5,000,000
1993 Employee Stock Purchase Plan (ESPP) [Member]
Note 13 - Stockholders' Equity (Details) - Number of Shares Available for Future Issuance [Line Items]
Shares available for future issuance	403,000

Note_13_Stockholders_Equity_De2

Note 13 - Stockholders' Equity (Details) - Stock Options, SARs and RSUs Activity (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Note 13 - Stockholders' Equity (Details) - Stock Options, SARs and RSUs Activity [Line Items]
Options outstanding at beginning of year (in Shares)	6,537,000	[1]	9,622,000	[1]	10,564,000
Options outstanding at beginning of year	$8.68	[1]	$10.72	[1]	$12.22
Options outstanding at beginning of year (in Dollars)		[2]		[2]		[2]
Options granted (in Shares)	232,000		524,000		310,000
Options granted	$9.15		$6.42		$5.67
Options granted		[2]		[2]		[2]
Non-options granted	$9.15		$6.42		$5.67
Non-options granted		[2]		[2]		[2]
Exercised (in Shares)	-1,715,000		-2,105,000		-127,000
Exercised	$7.92		$6.49		$5.97
Exercised (in Dollars)	3,537	[2]	3,795	[2]	62	[2]
Forfeited and cancelled (in Shares)	-747,000		-2,056,000		-2,225,000
Forfeited and cancelled	$20.11		$17.56		$15.14
Forfeited and cancelled (in Dollars)		[2]		[2]		[2]
Options/SARs/RSUs outstanding at end of year (2) (in Shares)	4,644,000	[1]	6,537,000	[1]	9,622,000	[1]
Options/SARs/RSUs outstanding at end of year (2)	$6.52	[1]	$8.68	[1]	$10.72	[1]
Options/SARs/RSUs outstanding at end of year (2) (in Dollars)	21,409	[1],[2]	16,673	[1],[2]	98	[1],[2]
Options/SARs/RSUs exercisable at end of year (3) (in Shares)	3,106,000	[3]	4,623,000	[3]	7,223,000	[3]
Options/SARs/RSUs exercisable at end of year (3)	$7.73	[3]	$10.30	[3]	$12.07	[3]
Options/SARs/RSUs exercisable at end of year (3) (in Dollars)	$10,941	[2],[3]	$7,230	[2],[3]	$28	[2],[3]
Stock Appreciation Rights (SARs) [Member]
Note 13 - Stockholders' Equity (Details) - Stock Options, SARs and RSUs Activity [Line Items]
Options granted		[4]		[4]	$6.16	[4]
Options granted		[2],[4]		[2],[4]		[2],[4]
Non-options granted (in Shares)		[4]		[4]	1,100,000	[4]
Non-options granted		[4]		[4]	$6.16	[4]
Non-options granted		[2],[4]		[2],[4]		[2],[4]
Restricted Stock Units (RSUs) [Member]
Note 13 - Stockholders' Equity (Details) - Stock Options, SARs and RSUs Activity [Line Items]
Options granted		[2]		[2]		[2]
Non-options granted (in Shares)	337,000		552,000
Non-options granted		[2]		[2]		[2]

[1]	Due to the ceiling imposed on the SAR grants, the outstanding amount above can be exercised for a maximum of 3,670,000 shares of the Company's commonstock as of December 31, 2014.
[2]	Calculation of aggregate intrinsic value for options, RSUs and SARs outstanding and exercisable is based on the share price of the Company's common stock as of December 31, 2014, 2013 and 2012 which was $10.87, $9.71 and $5.76 per share, respectively. The intrinsic value for options and SARs exercised during those years represents the difference between the fair market value of the Company's common stock on the date of exercise and the exercise price of each option or SAR, as applicable.
[3]	Due to the ceiling imposed on the SAR grants, the exercisable amount above can be exercised for a maximum of 2,279,000 shares of the Company's commonstock as of December 31, 2014.
[4]	SAR grants made prior to January 1, 2009 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SAR unitssubject to the grant. SAR grants made on or after January 1, 2009 and before January 1, 2010 are convertible for a maximum number of shares of the Company'scommon stock equal to 75% of the SAR units subject to the grant. SAR grants made on or after January 1, 2010 are convertible for a maximum number of shares of the Company's common stock equal to 66.67% of the SAR units subject to the grant. SAR grants made on or after January 1, 2012 are convertible for a maximum number of shares of the Company's common stock equal to 50% of the SAR units subject to the grant.

Note_13_Stockholders_Equity_De3

Note 13 - Stockholders' Equity (Details) - Stock Options and SARs Outstanding by Exercise Price Range (USD $)	12 Months Ended
	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding (in Shares)	4,644,000
Remaining contractual life (years)	3 years 153 days
Weighted average exercise price	$6,520
Exercisable (in Shares)	3,106,000
Remaining contractual life (years)	2 years 266 days
Weighted average exercise price	$7,730
Restricted Stock [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding (in Shares)	660,000
Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price	$5,210
Outstanding (in Shares)	2,484,000
Remaining contractual life (years)	3 years 142 days
Weighted average exercise price	$6,460
Exercisable (in Shares)	1,941,000
Remaining contractual life (years)	2 years 339 days
Weighted average exercise price	$6,550
Range of exercise price	$7,260
Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price	$7,490
Outstanding (in Shares)	1,345,000
Remaining contractual life (years)	3 years 259 days
Weighted average exercise price	$8,440
Exercisable (in Shares)	1,010,000
Remaining contractual life (years)	2 years 197 days
Weighted average exercise price	$8,330
Range of exercise price	$10,230
Range 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price	$11,600
Outstanding (in Shares)	65,000
Remaining contractual life (years)	1 year 324 days
Weighted average exercise price	$12,520
Exercisable (in Shares)	65,000
Remaining contractual life (years)	1 year 324 days
Weighted average exercise price	$12,520
Range of exercise price	$15,790
Range 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise price	$21,070
Outstanding (in Shares)	90,000
Remaining contractual life (years)	1 year
Weighted average exercise price	$23,030
Exercisable (in Shares)	90,000
Remaining contractual life (years)	1 year
Weighted average exercise price	$23,030
Range of exercise price	$25,060

Note_13_Stockholders_Equity_De4

Note 13 - Stockholders' Equity (Details) - Weighted Average Fair Value Assumptions	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Weighted Average Fair Value Assumptions [Abstract]
Volatility	43.14%		46.24%		48.23%
Risk-free interest rate	1.85%		1.39%		2.20%
Dividend yield	0.00%		0.00%		0.00%
Pre-vest cancellation rate *)	4.17%	[1]	3.48%	[1]	3.50%	[1]
Post-vest cancellation rate **)	4.09%	[2]	2.52%	[2]	2.58%	[2]
Suboptimal exercise factor ***)	1.61%	[3]	1.81%	[3]	1.60%	[3]
Expected life (years)	3 years 98 days		4 years 240 days		4 years 69 days

[1]	The pre-vest cancellation rate was calculated on an annual basis and is presented here on an annual basis.
[2]	The post-vest cancellation rate was calculated on a monthly basis and is presented here on an annual basis.
[3]	The ratio of the stock price to strike price at the time of exercise of the option.

Note_13_Stockholders_Equity_De5

Note 13 - Stockholders' Equity (Details) - Non-vested Stock Options, SARs and RSUs (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014
Non-vested Stock Options, SARs and RSUs [Abstract]
Non-vested at January 1, 2014	1,914
Non-vested at January 1, 2014	$4.14
Granted	569
Granted	$6.12
Vested	-918
Vested	$3.89
Forfeited	-27
Forfeited	$4.26
Non-vested at December 31, 2014	1,538
Non-vested at December 31, 2014	$5.01

Note_14_Commitments_and_Contin2

Note 14 - Commitments and Contingencies (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 14 - Commitments and Contingencies (Details) [Line Items]
Operating Leases, Rent Expense	$2,298	$2,389	$2,891
Isreaeli Office of the Chief ScientistR oyalties [Member]
Note 14 - Commitments and Contingencies (Details) [Line Items]
Loss Contingency Accrual	$5,290

Note_14_Commitments_and_Contin3

Note 14 - Commitments and Contingencies (Details) - Minimum Lease Payments (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified	Dec. 31, 2014
Minimum Lease Payments [Abstract]
2015	$2,977
2016	2,584
2017	1,687
2018 and thereafter	1,360
	$8,608

Note_15_Taxes_On_Income_Detail

Note 15 - Taxes On Income (Details) (USD $)	12 Months Ended
Note 15 - Taxes On Income (Details) (USD $)	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Note 15 - Taxes On Income (Details) [Line Items]
Current Foreign Tax Expense (Benefit)	($1,672,000)	[1]	$507,000	[1]	$304,000	[1]
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	-827,000
Income Tax Expense (Benefit)	-2,841,000		-150,000		-172,000
Deferred Tax Assets, Valuation Allowance	33,115,000		36,886,000
Cash and Cash Equivalents,Marketable Securities,and Time Deposit	124,300,000
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	1,031,000		1,892,000
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	135,000		408,000
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	858,000		284,000		622,000
Approved Enterprise [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Tax Exemption Period	2 years
Corporate Tax Rate	10.00%
Additional Tax Exemption Period	8 years
Approved Enterprise [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Number of Investments	6
Beneficiary Enterprise [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Tax Exemption Period	4 years
Corporate Tax Rate	25.00%
Additional Tax Exemption Period	6 years
Beneficiary Enterprise [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Number of Investments	2
First, Second, Third, Fourth, Fifth and Sixth Investment Programs [Member] \| Minimum [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Tax Exemption Period			2 years
Corporate Tax Rate			10.00%
Additional Tax Exemption Period			6 years
First, Second, Third, Fourth, Fifth and Sixth Investment Programs [Member] \| Maximum [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Tax Exemption Period			4 years
Corporate Tax Rate			25.00%
Additional Tax Exemption Period			8 years
Seventh and Eighth Investment Programs [Member] \| Minimum [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Corporate Tax Rate	10.00%
Seventh and Eighth Investment Programs [Member] \| Maximum [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Corporate Tax Rate	25.00%
Seventh and Eighth Investment Programs [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Tax Exemption Period	2 years
Additional Tax Exemption Period	8 years
Preferred Enterprises [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Corporate Tax Rate	16.00%
Dividend Tax Rate	20.00%
Non Qualified Stock Options [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Income Tax Expense (Benefit)	0		0		0
Domestic Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Operating Loss Carryforwards	12,012
Foreign Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Operating Loss Carryforwards	2,515
Investment held by Foreign Entities [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Cash and Cash Equivalents,Marketable Securities,and Time Deposit	108,800,000
Valuation Allowance, Tax Credit Carryforward [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Current Foreign Tax Expense (Benefit)	-1,234,000
Minimum [Member] \| Swiss Federal Tax Administration (FTA) [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Foreign Reduced Tax Rates	10.00%
Minimum [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Tax Credit Carryforward, Expiration Period	15 years
Maximum [Member] \| Swiss Federal Tax Administration (FTA) [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Foreign Reduced Tax Rates	15.00%
Maximum [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Tax Credit Carryforward, Expiration Period	20 years
Finalization of Tax Assessment [Member] \| Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Income Tax Expense (Benefit)	-858,000
Israel Tax Authority [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Current Foreign Tax Expense (Benefit)	-858,000
Percentage of Export Sales to Get Tax Benefit	25.00%
Corporate Tax Rate	26.50%		25.00%		25.00%
Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount	33,293
Income Tax, Net Liabilities	3,699
Operating Loss Carryforwards	24,236
Swiss Federal Tax Administration (FTA) [Member]
Note 15 - Taxes On Income (Details) [Line Items]
Deferred Tax, Amortization Period	10 years
Operating Loss Carryforwards	$215,450
Capital Loss Carryforward, Expiration Period	7 years

[1]	Includes (i) income in the amount of $858 due to reversal of income tax contingency reserves that were determined to be no longer needed due to finalization of a tax assessment of one of the Company's subsidiaries and (ii) income in the amount of $1,234 due to removal of valuation allowance of tax advances.

Note_15_Taxes_On_Income_Detail1

Note 15 - Taxes On Income (Details) - Provision for Income Taxes (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Domestic taxes
Current			($271)		($465)
Current	2		-9		1
Current (1)	-1,672	[1]	507	[1]	304	[1]
Deferred (2)	-1,170	[2]	-377	[2]	-12	[2]
	-2,842		130		292
Income tax benefit	($2,841)		($150)		($172)

[1]	Includes (i) income in the amount of $858 due to reversal of income tax contingency reserves that were determined to be no longer needed due to finalization of a tax assessment of one of the Company's subsidiaries and (ii) income in the amount of $1,234 due to removal of valuation allowance of tax advances.
[2]	Includes income tax benefit in the amount of $827 due to elimination of valuation allowance of deferred tax assets.

Note_15_Taxes_On_Income_Detail2

Note 15 - Taxes On Income (Details) - Income (Loss) Before Taxes (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income (Loss) Before Taxes [Abstract]
Domestic	($3,497)	($3,525)	($844)
Foreign	4,258	6,051	-7,370
	$761	$2,526	($8,214)

Note_15_Taxes_On_Income_Detail3

Note 15 - Taxes On Income (Details) - Income Tax Reconciliation (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Reconciliation [Abstract]
Income (loss) before taxes on income	$761	$2,526	($8,214)
Theoretical tax at U.S. statutory tax rate (35%)	266	884	-2,875
State taxes, net of federal benefit	2	2	2
Foreign income taxed at rates other than the U.S. rate (including deferred taxes that were not provided, valuation allowance and current adjustment and interest on uncertain tax position liability)	-5,974	-3,015	1,253
Nondeductible equity-based compensation expenses	1,876	1,456	1,744
Current adjustment and interest on uncertain tax position liability in U.S.		-283	-465
Valuation allowance in U.S.	989	804	154
Other	1	2	15
	($2,841)	($150)	($172)

Note_15_Taxes_On_Income_Detail4

Note 15 - Taxes On Income (Details) - Income Tax Reconciliation (Parentheticals)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Reconciliation [Abstract]
U.S. statutory tax rate	35.00%	35.00%	35.00%

Note_15_Taxes_On_Income_Detail5

Note 15 - Taxes On Income (Details) - Deferred Tax Assets and Liabilities (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Deferred Tax Assets and Liabilities [Abstract]
Reserves and accruals	$149	$92
Carryforward tax losses	626
Total deferred tax assets (short-term)	775	92
Total	775	92
Reserves and accruals	1,669	1,074
Equity-based compensation	2,761	2,526
Intangible assets	1,198	1,453
Carryforward tax losses	27,621	31,817
Other	15	16
Total deferred tax assets (long-term)	33,264	36,886
Valuation allowance	-33,115	-36,886
Total	149
Total deferred tax assets	924	92
Acquired intangible assets	1,360	1,670
Acquired carryforward tax losses	-515	-487
Total deferred tax liabilities, net	$845	$1,183

Note_15_Taxes_On_Income_Detail6

Note 15 - Taxes On Income (Details) - Uncertain Tax Positions (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Uncertain Tax Positions [Abstract]
Gross unrecognized tax benefits at January 1	$1,892	$1,815
Decrease in tax positions for previous years	-104
Increases in tax positions for previous years	115	59
Increases in tax positions for current year	71	109
Change in interest and linkage related to tax positions	-85	193
Lapse in statute of limitations or finalization of tax assessment	-858	-284	-622
Gross unrecognized tax benefits at December 31	$1,031	$1,892	$1,815

Note_16_Basic_and_Diluted_Loss2

Note 16 - Basic and Diluted Loss Per Share (Details) - Net Income (Loss) Per Share (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Numerator:
Net income (loss) (in Dollars)	$3,602	$2,676	($8,042)
Denominator:
Weighted average number of shares of common stock outstanding during the year used to compute basic net income (loss) per share (in thousands)	21,968	22,249	21,950
Incremental shares attributable to exercise of outstanding options, SARs and RSUs (assuming proceeds would be used to purchase treasury stock) (in thousands)	986	657
Weighted average number of shares of common stock used to compute diluted net income (loss) per share (in thousands)	22,954	22,906	21,950
Basic net income (loss) per share (in Dollars per share)	$0.16	$0.12	($0.37)
Diluted net income (loss) per share (in Dollars per share)	$0.16	$0.12	($0.37)

Note_17_Restructuring_Costs_an1

Note 17 - Restructuring Costs and Other (Details) (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2012	Jun. 30, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Restructuring and Related Activities [Abstract]
Severance Costs	$1,315	$693	$1,568	$1,494	$1,660
Restructuring Reserve, Current			$39

Note_18_Segment_Information_De

Note 18 - Segment Information (Details)	3 Months Ended		12 Months Ended
Note 18 - Segment Information (Details)	Sep. 30, 2012	Jun. 30, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 18 - Segment Information (Details) [Line Items]
Number of Reportable Segments	3	1
Home [Member] \| Sales Revenue, Segment [Member]
Note 18 - Segment Information (Details) [Line Items]
Concentration Risk, Percentage			79.00%	85.00%	88.00%
Office [Member] \| Sales Revenue, Segment [Member]
Note 18 - Segment Information (Details) [Line Items]
Concentration Risk, Percentage			0.00%	0.00%	0.00%

Note_18_Segment_Information_De1

Note 18 - Segment Information (Details) - Selected Operating Results (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting Information [Line Items]
Revenues	$143,036	$151,063	$162,790
Income (loss) from operations	8,650	9,671	1,299
Home [Member]
Segment Reporting Information [Line Items]
Revenues	128,690	142,144	155,211
Income (loss) from operations	23,438	25,367	15,040
Office [Member]
Segment Reporting Information [Line Items]
Revenues	14,276	8,849	7,579
Income (loss) from operations	-2,805	-4,656	-5,156
Mobile [Member]
Segment Reporting Information [Line Items]
Revenues	70	70
Income (loss) from operations	($11,983)	($11,040)	($8,585)

Note_18_Segment_Information_De2

Note 18 - Segment Information (Details) - Reconciliation of Segment Operating Results (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of Segment Operating Results [Abstract]
Income from operations	$8,650	$9,671	$1,299
Unallocated corporate, general and administrative expenses *	-2,161	-2,368	-2,600
Restructuring expenses			-2,008
Proxy contest related expenses		-1,403
Equity-based compensation expenses	-5,359	-4,159	-4,983
Intangible assets amortization expenses	-1,573	-1,672	-2,310
Financial income, net	1,204	2,457	2,388
Total consolidated income (loss) before taxes	$761	$2,526	($8,214)

Note_18_Segment_Information_De3

Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations [Line Items]
Revenue distribution	$143,036	$151,063	$162,790
HONG KONG
Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations [Line Items]
Revenue distribution	79,622	86,090	84,737
JAPAN
Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations [Line Items]
Revenue distribution	31,261	34,377	51,033
Europe [Member]
Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations [Line Items]
Revenue distribution	6,787	7,370	7,429
UNITED STATES
Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations [Line Items]
Revenue distribution	4,702	4,342	2,028
CHINA
Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations [Line Items]
Revenue distribution	6,568	6,999	6,270
TAIWAN, PROVINCE OF CHINA
Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations [Line Items]
Revenue distribution	9,077	7,093	6,496
Other Geographic Regions [Member]
Note 18 - Segment Information (Details) - Summary of Operations Within Geographic Areas Based On Customer Locations [Line Items]
Revenue distribution	$5,019	$4,792	$4,797

Note_18_Segment_Information_De4

Note 18 - Segment Information (Details) - Summary of Long-lived Assets Within Geographic Areas Based On the Assets' Locations (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Note 18 - Segment Information (Details) - Summary of Long-lived Assets Within Geographic Areas Based On the Assets' Locations [Line Items]
Long-lived assets	$2,843	$2,837
Europe [Member]
Note 18 - Segment Information (Details) - Summary of Long-lived Assets Within Geographic Areas Based On the Assets' Locations [Line Items]
Long-lived assets	188	158
ISRAEL
Note 18 - Segment Information (Details) - Summary of Long-lived Assets Within Geographic Areas Based On the Assets' Locations [Line Items]
Long-lived assets	2,264	2,260
UNITED STATES
Note 18 - Segment Information (Details) - Summary of Long-lived Assets Within Geographic Areas Based On the Assets' Locations [Line Items]
Long-lived assets		1
Other Geographic Regions [Member]
Note 18 - Segment Information (Details) - Summary of Long-lived Assets Within Geographic Areas Based On the Assets' Locations [Line Items]
Long-lived assets	$391	$418